Astra Space Inc - Ordinary Shares (ASTR) 10-Q 14 Aug 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 10, 2023
Document Information [Line Items]
Document Quarterly Report	true
Document Transition Report	false
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	001-39426
Entity Central Index Key	0001814329
Entity Registrant Name	ASTRA SPACE, INC.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1900 Skyhawk Street
Entity Address, City or Town	Alameda
Entity Address, State or Province	CA
Entity Tax Identification Number	85-1270303
Entity Address, Postal Zip Code	94501
City Area Code	866
Local Phone Number	278-7217
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	ASTR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Document Fiscal Period Focus	Q2
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		217,501,756
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		55,539,188

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 13,384	$ 33,644
Marketable securities	12,935	69,173
Trade accounts receivable	5,546	5,327
Inventories	11,231	4,142
Prepaid and other current assets	15,757	13,496
Total current assets	58,853	125,782
Non-current assets:
Property, plant and equipment, net	28,301	24,271
Right-of-use asset	11,096	12,813
Intangible assets, net	8,999	10,132
Other non-current assets	1,847	1,701
Total assets	109,096	174,699
Current liabilities:
Accounts payable	7,187	1,799
Operating lease obligation, current portion	3,797	3,800
Contingent consideration	14,510	33,900
Accrued expenses and other current liabilities	40,262	42,043
Total current liabilities	65,756	81,542
Non-current liabilities:
Operating lease obligation, net of current portion	7,548	9,051
Other non-current liabilities	8,629	1,796
Total liabilities	81,933	92,389
Commitments and Contingencies (Note 7)
STOCKHOLDERS' EQUITY
Additional paid in capital	1,905,870	1,902,213
Accumulated other comprehensive loss	(17)	(110)
Accumulated deficit	(1,878,718)	(1,819,821)
Total stockholders' equity	27,163	82,310
Total liabilities and stockholders' equity	109,096	174,699
Preferred Stock [Member]
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of June 30, 2023 and December 31, 2022	0	0
Common Class A [Member]
STOCKHOLDERS' EQUITY
Common stock Value	22	22
Common Class B [Member]
STOCKHOLDERS' EQUITY
Common stock Value	$ 6	$ 6

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock, shares outstanding	0
Common stock, shares authorized	466,000,000
Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Class A [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	216,481,966	216,481,966
Common stock, shares outstanding	213,697,468	213,697,468
Common Class B [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	65,000,000	65,000,000
Common stock, shares issued	55,539,188	55,539,188
Common stock, shares outstanding	55,539,188	55,539,188

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue	$ 707	$ 2,682	$ 707	$ 6,593
Cost of Revenue	388	17,445	388	28,459
Gross profit (loss)	319	(14,763)	319	(21,866)
Operating expenses:
Research and development	24,395	40,798	55,477	78,725
Sales and marketing	650	4,636	3,134	9,400
General and administrative	7,580	20,608	23,262	41,594
(Gain) Loss on change in fair value of contingent consideration	(16,625)	1,800	(19,390)	17,300
Total operating expenses	16,000	67,842	62,483	147,019
Operating loss	(15,681)	(82,605)	(62,164)	(168,885)
Interest income	384	356	1,714	530
Other income (expense), net	1,293	(54)	1,553	339
Loss before taxes	(14,004)	(82,303)	(58,897)	(168,016)
Income tax provision	0	0	0	0
Net loss	(14,004)	(82,303)	(58,897)	(168,016)
Launch Services [Member]
Revenue	0	1,988	0	5,899
Cost of Revenue	0	17,179	0	28,193
Gross profit (loss)	0	(15,191)	0	(22,294)
Space Products [Member]
Revenue	707	694	707	694
Cost of Revenue	388	266	388	266
Gross profit (loss)	$ 319	$ 428	$ 319	$ 428
Common Class A [Member]
Earnings Per Share [Abstract]
Earnings Per Share Basic	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Earnings Per Share Diluted	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Dilutive weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Basic weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Common Class B [Member]
Earnings Per Share [Abstract]
Earnings Per Share Basic	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Earnings Per Share Diluted	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Dilutive weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188
Basic weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188

Condensed Consolidated Statemen

Condensed Consolidated Statement of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Other Comprehensive Income [Abstract]
Net loss	$ (14,004)	$ (82,303)	$ (58,897)	$ (168,016)
Other comprehensive loss:
Unrealized gain (loss) on available-for-sale marketable securities	24	(78)	93	(233)
Total comprehensive loss	$ (13,980)	$ (82,381)	$ (58,804)	$ (168,249)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Temporary Equity and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member] Common Class A [Member]	Common Stock [Member] Common Class B [Member]	Additional Paid in Capital [Member]	Accumulated Other Comprehensive loss [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2021	$ 436,520	$ 22	$ 6	$ 1,844,875		$ (1,408,383)
Beginning Balance (in shares) at Dec. 31, 2021		207,451,107	55,539,188
Stock-based compensation	17,041			17,041
Issuance Of Common Stock Under Equity Plans, Shares		1,159,383
Issuance Of Common Stock Under Equity Plans	793			793
Unrealized gain (loss) on available-for-sale marketable securities	(155)				$ (155)
Net loss	(85,713)					(85,713)
Ending Balance at Mar. 31, 2022	368,486	$ 22	$ 6	1,862,709	(155)	(1,494,096)
Ending Balance (in shares) at Mar. 31, 2022		208,610,490	55,539,188
Beginning Balance at Dec. 31, 2021	436,520	$ 22	$ 6	1,844,875		(1,408,383)
Beginning Balance (in shares) at Dec. 31, 2021		207,451,107	55,539,188
Net loss	(168,016)
Ending Balance at Jun. 30, 2022	298,923	$ 22	$ 6	1,875,527	(233)	(1,576,399)
Ending Balance (in shares) at Jun. 30, 2022		209,408,425	55,539,188
Beginning Balance at Mar. 31, 2022	368,486	$ 22	$ 6	1,862,709	(155)	(1,494,096)
Beginning Balance (in shares) at Mar. 31, 2022		208,610,490	55,539,188
Stock-based compensation	12,791			12,791
Issuance Of Common Stock Under Equity Plans, Shares		797,935
Issuance Of Common Stock Under Equity Plans	27			27
Unrealized gain (loss) on available-for-sale marketable securities	(78)				(78)
Net loss	(82,303)					(82,303)
Ending Balance at Jun. 30, 2022	298,923	$ 22	$ 6	1,875,527	(233)	(1,576,399)
Ending Balance (in shares) at Jun. 30, 2022		209,408,425	55,539,188
Beginning Balance at Dec. 31, 2022	82,310	$ 22	$ 6	1,902,213	(110)	(1,819,821)
Beginning Balance (in shares) at Dec. 31, 2022		213,697,468	55,539,188
Stock-based compensation	5,328			5,328
Issuance Of Common Stock Under Equity Plans, Shares		1,588,976
Issuance Of Common Stock Under Equity Plans	441			441
Unrealized gain (loss) on available-for-sale marketable securities	69				69
Net loss	(44,893)					(44,893)
Ending Balance at Mar. 31, 2023	43,255	$ 22	$ 6	1,907,982	(41)	(1,864,714)
Ending Balance (in shares) at Mar. 31, 2023		215,286,444	55,539,188
Beginning Balance at Dec. 31, 2022	82,310	$ 22	$ 6	1,902,213	(110)	(1,819,821)
Beginning Balance (in shares) at Dec. 31, 2022		213,697,468	55,539,188
Net loss	(58,897)
Ending Balance at Jun. 30, 2023	27,163	$ 22	$ 6	1,905,870	(17)	(1,878,718)
Ending Balance (in shares) at Jun. 30, 2023		216,481,966	55,539,188
Beginning Balance at Mar. 31, 2023	43,255	$ 22	$ 6	1,907,982	(41)	(1,864,714)
Beginning Balance (in shares) at Mar. 31, 2023		215,286,444	55,539,188
Stock-based compensation	(2,124)			(2,124)
Issuance Of Common Stock Under Equity Plans, Shares		1,195,522
Warrants	12			12
Unrealized gain (loss) on available-for-sale marketable securities	24				24
Net loss	(14,004)					(14,004)
Ending Balance at Jun. 30, 2023	$ 27,163	$ 22	$ 6	$ 1,905,870	$ (17)	$ (1,878,718)
Ending Balance (in shares) at Jun. 30, 2023		216,481,966	55,539,188

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (58,897)	$ (168,016)
Adjustments to reconcile net loss to cash flows used in operating activities
Stock-based compensation	3,216	29,832
Depreciation	1,900	6,004
Amortization of intangible assets	1,133	1,629
Inventory write-downs	0	18,828
Non-cash lease expense	1,716	729
Loss (Gain) on change in fair value of contingent consideration	(19,390)	17,300
Accretion (amortization) of marketable securities purchased at a premium (discount)	(679)	132
Trade accounts receivable	(219)	(1,632)
Inventories	(7,089)	(13,446)
Prepaid and other current assets	(2,261)	7,447
Other non-current assets	(146)	(2,393)
Accounts payable	7,783	6,268
Lease liabilities	(1,506)	(631)
Accrued expenses and other current liabilities	(1,885)	1,153
Other non-current liabilities	6,836	4,934
Net cash used in operating activities	(69,488)	(91,862)
Cash flows from investing activities:
Acquisition of trademark	0	(850)
Purchases of marketable securities	0	(102,010)
Proceeds from maturities of marketable securities	57,010	5,277
Purchases of property, plant and equipment	(8,223)	(32,064)
Net cash provided by (used in) investing activities	48,787	(129,647)
Cash flows from financing activities:
Proceeds from issuance of common stock under equity plans	441	106
Proceeds from Employee Stock Purchase Plans	0	711
Net cash provided by financing activities	441	817
Net decrease in cash and cash equivalents	(20,260)	(220,692)
Cash and cash equivalents at beginning of period	33,644	325,007
Cash and cash equivalents at end of period	13,384	104,315
Non-cash investing and financing activities:
Assets acquired included in accounts payable, accrued expenses and other current liabilities	$ 1,062	$ 4,983

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Description of Business, Basis of Presentation and Significant Accounting Policies	Note 1 — Description of Business, Basis of Presentation and Significant Accounting Policies Description of Business Astra Space, Inc. (the "Company") designs, tests, manufactures and operates the next generation of launch services and space products and services that it expects to enable a new generation of global communications, earth observation, precision weather monitoring, navigation, and surveillance capabilities. The Company's mission is to Improve Life on Earth from Space® through greater connectivity and more regular observation and to enable a wave of innovation in Low Earth Orbit ("LEO") by expanding its space platform offerings. Currently, the Company's business consists of two segments, a mobile orbital launch system (“Launch Services”) and a space products business that produces the Astra Spacecraft Engine TM products (“Space Products”). Holicity Inc. (“Holicity”) was originally incorporated in Delaware and was established as a special purpose acquisition company, which completed its initial public offering in August 2020. On June 30, 2021 (the “Closing Date”), Holicity consummated a business combination (the “Business Combination”) pursuant to the Business Combination Agreement dated as of February 2, 2021 (the “BCA”), by and among Holicity, Holicity Merger Sub Inc., a wholly owned subsidiary of Holicity (“Merger Sub”), and Astra Space Operations, Inc. (“pre-combination Astra”). Immediately upon the consummation of the Business Combination, Merger Sub merged with and into pre-combination Astra with pre-combination Astra surviving the merger as a wholly owned subsidiary of Holicity. Holicity changed its name to “Astra Space, Inc.” and pre-combination Astra changed its name to “Astra Space Operations, Inc.” Unless the context otherwise requires, “Astra” and the “Company” refers to Astra Space, Inc., the combined company and its subsidiaries following the Business Combination and Astra Space Operations, Inc. prior to the Business Combination. See Note 3 — Acquisitions for further discussion of the Business Combination, included in the Notes to Consolidated Financial Statements in Astra’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission (the "SEC") on March 30, 2023 (“2022 Annual Report”). The Company’s Class A common stock is listed on the Nasdaq under the symbol “ASTR”. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Astra and its subsidiaries, and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for financial reporting. The condensed consolidated financial statements included herein are unaudited, and reflect all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the periods presented. The condensed consolidated balance sheet data as of December 31, 2022 were derived from Astra’s audited consolidated financial statements included in its 2022 Annual Report. All intercompany transactions and balances have been eliminated in consolidation. The operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 , or for any other future period. Reclassification Certain prior period amounts have been reclassified to conform to the current period presentation. The impact of these reclassifications was not material to the condensed financial statements for the periods presented. Liquidity The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these unaudited condensed consolidated financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of ASC Topic 205-40, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern , management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within the control of the Company as of the date the unaudited condensed consolidated financial statements are issued. When substantial doubt exists, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the unaudited condensed consolidated financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The Company evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern over the next twelve months through August 2024. Since inception, the Company has incurred significant operating losses and has an accumulated deficit of approximately $ 1.9 billion . As of June 30, 2023, the Company’s existing sources of liquidity included cash and cash equivalents of $ 13.4 million and marketable securities of $ 12.9 million . The Company believes that its current level of cash and cash equivalents and marketable securities are not sufficient to fund commercial scale production and sale of its services and products. These conditions raise substantial doubt regarding its ability to continue as a going concern for a period of at least one year from the date of issuance of these unaudited condensed consolidated financial statements. In order to proceed with the Company’s business plan, the Company will need to raise substantial additional funds through the issuance of additional debt, equity or both. Until such time, if ever, the Company can generate revenue sufficient to achieve profitability, the Company expects to finance its operations through equity or debt financing, which may not be available to the Company on the timing needed or on terms that the Company deems to be favorable. To the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the ownership interest of its stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting the Company’s ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If the Company is unable to obtain sufficient financial resources, its business, financial condition and results of operations will be materially and adversely affected. The Company may be required to delay, limit, reduce or terminate its product development activities or future commercialization efforts. There can be no assurance that the Company will be able to obtain the needed financing on acceptable terms or at all. In an effort to alleviate these conditions, the Company continues to seek and evaluate opportunities to raise additional capital through the issuance of equity or debt securities. The Company's ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, its performance and investor sentiment with respect to the Company and its industry. See Note 8 – Stockholders’ Equity and Note 12 - Subsequent Events for additional information about financing arrangements entered into since June 30, 2023. As a result of these uncertainties, and notwithstanding management’s plans and efforts to date, there is substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to raise substantial additional capital in the near term, the Company's operations and production plans will be scaled back or curtailed. See Note 12 - Subsequent Events for restructuring activities the Company has implemented since June 30, 2023. If the funds raised are insufficient to provide a bridge to full commercial production at a profit, the Company's operations could be severely curtailed or cease entirely and the Company may not realize any significant value from its assets. The Company has, however, prepared these unaudited condensed consolidated financial statements on a going concern basis, assuming that the Company's financial resources will be sufficient to meet its capital needs over the next twelve months. Accordingly, the Company's financial statements do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should it be unable to continue in operation. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, marketable securities, and accounts receivable. The Company maintains cash and cash equivalent balances in bank accounts with multiple banking partners. All cash accounts are located in the United States (“U.S.”) and insured by the FDIC up to $ 250,000 . Marketable securities consist of highly liquid investments with financial institutions, which management believes to be of a high credit quality. The Company's accounts receivable are derived from revenue earned from customers or invoices billed to customer that represent unconditional right to consideration located within the U.S. The Company mitigates collection risks from its customers by performing regular credit evaluations of the Company's customers’ financial conditions. The Company believes there is no exposure to any significant credit risks related to its cash and cash equivalents or accounts receivable and has not experienced any losses in such accounts. As of June 30, 2023 and December 31, 2022, the following customers accounted for greater than 10 % of the Company's trade accounts receivable: June 30, 2023 December 31, 2022 Customer 1 25.7 % 21.7 % Customer 2 20.7 % 53.3 % Customer 3 16.5 % 20.8 % Customer 4 13.2 % — Customer 5 10.3 % — For the three and six months ended June 30, 2023 and 2022 , the following customers accounted for greater than 10 % of the Company's total revenues: Three Months Ended Six Months Ended 2023 2022 2023 2022 Customer 4 100.0 % — 100 % — Customer 6 — 90.9 % — 84.1 % Customer 7 — (1) — 10.5 % ____________ (1) These customers accounted for less than 10 % of the recognized revenue for the period. Use of Estimates and Judgments The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the unaudited condensed consolidated financial statements and accompanying notes. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill and long-lived assets, inventory valuation and reserves, stock-based compensation, pre-combination Astra common stock, useful lives of intangible assets and property, plant and equipment, deferred tax assets, income tax uncertainties, contingent consideration, and other contingencies. Significant Accounting Policies There have been no changes to the Company’s significant accounting policies described in the Company’s 2022 Annual Report that have had a material impact on its unaudited condensed consolidated financial statements and related notes. Recently Adopted Accounting Standards In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. The Company adopted the ASU on January 1, 2023. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows. Recently Issued Accounting Standards Not Yet Adopted In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848), Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provided temporary relief when transitioning from the London Interbank Offered Rate (“LIBOR”) to the Secured Overnight Financing Rate (“SOFR”) or another applicable rate during the original transition period ending on December 31, 2022. In March 2021, the UK Financial Conduct Authority (the “FCA”) announced that the intended cessation date of the overnight 1-, 3-, 6-, and 12-month tenors of U.S. dollar LIBOR would be June 30, 2023, which is beyond the current sunset date of Topic 848. In light of this development, the FASB issued this update to defer the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company does not anticipate this new guidance to have a material impact on its financial position, results of operations, cash flows, or related disclosures.

Revenues

Revenues	6 Months Ended
	Jun. 30, 2023
Revenues [Abstract]
Revenues	Note 2 — Revenues The work performed by the Company in fulfilling Launch Services and Space Products performance obligations is not expected to create an asset to the customer since the launch vehicle that is built to deliver the customer’s payload into orbit will not be owned by the customer nor will the propulsion systems that are built to thrust the customers' satellite into orbit be controlled by the customer until they are delivered to the customer. The Company recognizes revenue at a point in time upon satisfaction of the performance obligations under its Launch Services and Space Products agreements . The following table presents revenue disaggregated by type for the periods presented: Three months ended Six Months Ended in thousands 2023 2022 2023 2022 Launch services $ — $ 1,988 $ — $ 5,899 Space products 707 694 707 694 Total revenues $ 707 $ 2,682 $ 707 $ 6,593 Contracts with governmental entities involving research and development milestone activities do not represent contracts with customers under ASC 606 and as such, amounts received are recorded in other income in the unaudited condensed consolidated statements of operations. $ 1.5 million such income was recorded for the three and six months ended June 30, 2023. No such income was recorded for the three months ended June 30, 2022. The Company recorded $ 0.4 million in other income for the six months ended June 30, 2022. Contract balances Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Contract assets become receivables once the Company's rights to consideration become unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due. The Company had deferred contract costs of $ 3.3 million and $ 2.4 million as of June 30, 2023 and December 31, 2022, respectively. The Company had contract liabilities of $ 33.1 million and $ 24.1 million as of June 30, 2023 and December 31, 2022, respectively. During both the three and six months ended June 30, 2023, the Company recognized $ 0.7 million of revenue that was included in the contract liabilities balance at the beginning of the periods. During the three and six months ended June 30, 2022, the Company recognized revenue of $ 2.7 million and $ 4.9 million, respectively, that was included in the contract liabilities balance at the beginning of the periods. Remaining performance obligations Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. Customers are not considered committed when they are able to terminate their contractual obligations to the Company without payment of a substantive penalty under the contract. The Company had unsatisfied performance obligations of $ 95.2 million as of June 30, 2023, $ 46.0 million of which is expected to be recognized by June 2024, and $ 49.2 million between July 2024 an d 2028.

Supplemental Financial Informat

Supplemental Financial Information	6 Months Ended
	Jun. 30, 2023
Supplemental Financial Information Abstract
Supplemental Financial Information	Note 3 — Supplemental Financial Information Inventories in thousands June 30, December 31, Raw materials $ 9,090 $ 2,622 Work in progress 2,141 1,520 Finished goods — — Inventories $ 11,231 $ 4,142 There were no invento ry write-downs recorded during the three and six months ended June 30, 2023. There were $ 13.3 million and $ 18.8 million of inventory write-downs recorded within cost of revenues during the three and six months ended June 30, 2022, respectively, of which $ 10.2 million of inventory write-downs related to the discontinuance of production of the former version of the Company's launch vehicle as it focuses on developing the new version of its launch system. The amounts as of December 31, 2022 have been revised to correct the classification of inventory between raw materials and work in progress and to correct the classification of deferred contract costs from inventory to prepaid and other current assets. Prepaid and other current assets in thousands June 30, December 31, Deposits $ 5,592 $ 379 Prepaid license and other prepaid expenses 3,030 3,589 Employee Retention Credit - Payroll Tax 2,101 4,283 Deferred contract costs 3,306 2,446 Other current assets 1,728 2,799 Prepaid and other current assets $ 15,757 $ 13,496 Property, Plant and Equipment, net Presented in the table below are the major classes of property, plant and equipment: in thousands June 30, December 31, Construction in progress $ 6,703 $ 8,309 Computer and software 2,924 2,810 Leasehold improvements 11,946 10,390 Research equipment 9,031 9,042 Production equipment 20,042 14,100 Furniture and fixtures 500 565 Total property, plant and equipment 51,146 45,216 Less: accumulated depreciation ( 22,845 ) ( 20,945 ) Property, plant and equipment, net $ 28,301 $ 24,271 Depreciation expense amounted to $ 1.1 million and $ 4.0 million for the three months ended June 30, 2023 and 2022, respectively. Depreciation expense amounted to $ 1.9 million and $ 6.0 million for the six months ended June 30, 2023 and 2022, respectively. No impairment charges were recorded for the three and six months ended June 30, 2023 and 2022. Accrued Expenses and Other Current Liabilities in thousands June 30, December 31, Employee compensation and benefits $ 3,133 $ 5,861 Contract liabilities, current portion 26,511 24,137 Construction in progress related accruals 320 2,692 Professional services 2,787 756 Accrued expenses 3,484 4,423 Accrued inventory purchases 3,110 2,848 Other (miscellaneous) 917 1,326 Accrued expenses and other current liabilities $ 40,262 $ 42,043 Other Non-Current Liabilities in thousands June 30, December 31, Contract liabilities, net of current portion $ 6,605 $ — Other (miscellaneous) 2,024 1,796 Other non-current liabilities $ 8,629 $ 1,796

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 4 — Intangible Assets in thousands Carrying Amount Accumulated Amortization Net Book Value June 30, 2023 Definite-lived intangible assets Developed technology $ 9,909 $ ( 3,687 ) $ 6,222 Customer contracts and related relationship 2,383 ( 1,712 ) 671 Trade names 123 ( 123 ) — Intangible assets subject to amortization 12,415 ( 5,522 ) 6,893 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 5,522 ) $ 8,999 There were no impairment charges for the three and six months ended June 30, 2023 and 2022. in thousands Carrying Amount Accumulated Amortization Net Book Value December 31, 2022 Definite-lived intangible assets Developed technology $ 9,909 $ ( 2,910 ) $ 6,999 Customer contracts and related relationship 2,383 ( 1,376 ) 1,007 Trade names 123 ( 103 ) 20 Intangible assets subject to amortization 12,415 ( 4,389 ) 8,026 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 4,389 ) $ 10,132 Based on the amount of intangible assets as of June 30, 2023, the expected amortization expense for each of the next five years and thereafter is as follows: in thousands Expected Amortization Expense 2023 (remainder) $ 1,114 2024 1,891 2025 1,555 2026 1,555 2027 778 Total Intangible assets subject to amortization $ 6,893

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 5 — Income Taxes The Company computes its provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjusts the provision for discrete tax items recorded in the period. There has historically been no federal or state provision for income taxes because the Company has incurred operating losses and maintains a full valuation allowance against its net deferred tax assets. For the three and six months ended June 30, 2023 and 2022 , the Company recognized no provision for income taxes consistent with the losses incurred and the valuation allowance against the deferred tax assets. Utilization of net operating loss carryforwards, tax credits and other attributes may be subject to future annual limitations due to the ownership change limitations provided by Section 382 of the Internal Revenue Code and similar state provisions. The Company files income tax returns in the U.S. federal jurisdiction and various states. The Company is not currently under examination by income tax authorities in federal, state or other jurisdictions. All tax returns will remain open for examination by the federal and state authorities for three and four years, respectively, from the date of utilization of any net operating loss or credits. On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15 % minimum tax on book income of certain large corporations, a 1 % excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company's current analysis of the provisions, the Company does not believe this legislation will have a material impact on its consolidated financial statements. The Company will continue to monitor for additional guidance related to the Act.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 6 — Fair Value Measurements The Company measures its financial assets and liabilities at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value, as follows: Level 1 Observable inputs, such as quoted prices in active markets for identical assets or liabilities; Level 2 Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3 Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The Company uses the market approach to measure fair value for its financial assets. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets. The carrying amounts of Company's financial instruments, which include cash equivalents, accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities and certain other current liabilities approximate fair value because of their short-term maturities. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis: in thousands June 30, 2023 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 327 $ — $ — $ 327 Marketable securities US Treasury securities 7,952 — — 7,952 Corporate debt securities — 4,983 — 4,983 Total financial assets $ 8,279 $ 4,983 $ — $ 13,262 Liabilities: Contingent consideration $ — $ — $ 14,510 $ 14,510 Total financial liabilities $ — $ — $ 14,510 $ 14,510 in thousands December 31, 2022 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 21,909 $ — $ — $ 21,909 Marketable securities US Treasury securities 14,713 — — 14,713 Corporate debt securities — 16,915 — 16,915 Commercial paper — 34,698 — 34,698 Asset backed securities — 2,847 — 2,847 Total financial assets $ 36,622 $ 54,460 $ — $ 91,082 Liabilities: Contingent consideration $ — $ — $ 33,900 $ 33,900 Total financial liabilities $ — $ — $ 33,900 $ 33,900 The following table presents a summary of the changes in fair value of the Company's Level 3 financial instruments: in thousands Contingent Consideration Fair value as of December 31, 2022 $ 33,900 Gain on change in fair value of contingent consideration ( 19,390 ) Fair value as of June 30, 2023 $ 14,510 in thousands Contingent Consideration Fair value as of December 31, 2021 $ 13,700 Loss on change in fair value of contingent consideration 17,300 Fair value as of June 30, 2022 $ 31,000 In connection with the Apollo Fusion, Inc. ("Apollo") acquisition, the Company was required to make contingent payments in cash and Class A common stock, subject to the Apollo assets achieving certain revenue and contract thresholds from the date of the acquisition through December 31, 2023. The fair value of the contingent consideration related to the acquisition of Apollo Fusion, Inc. (“Apollo”) is classified as a Level 3 financial instrument. As of June 30, 2023, given the limited number of months remaining in the earn-out period, the Company estimated the fair value of contingent consideration using its current forecast of eligible revenues and contracts through December 31, 2023. In all prior periods since the acquisition closed on July 1, 2021, the Company used a Monte Carlo simulation model to determine the fair value of the contingent consideration due to the significant variability of estimating future revenues and contracts during those prior periods. The Monte Carlo simulation considered assumptions including revenue volatility, risk free rates, discount rates and additional revenue discount rate. Additionally, other key assumptions used in the Monte Carlo simulation included forecasted revenues from new customers and probability of achieving them. The following table sets forth the significant assumptions utilized to determine the fair value of contingent consideration as of December 31, 2022: December 31, Risk-free interest rate 4.14 % Expected revenue volatility 19.00 % Revenue discount rate 10.00 % Discount rate 7.50 % The Company began investing in available-for-sale marketable securities in the first quarter of 2022. These marketable securities are classified as short term investments on the unaudited condensed consolidated balance sheets. The following is a summary of available-for-sale marketable securities as of June 30, 2023 and December 31, 2022: in thousands June 30, 2023 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 7,960 $ ( 8 ) $ 7,952 Corporate debt securities 4,992 ( 9 ) 4,983 Total available-for-sale marketable securities $ 12,952 $ ( 17 ) $ 12,935 in thousands December 31, 2022 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 14,763 $ ( 50 ) $ 14,713 Corporate debt securities 16,972 ( 57 ) 16,915 Commercial paper 34,698 — 34,698 Asset backed securities 2,850 ( 3 ) 2,847 Total available-for-sale marketable securities $ 69,283 $ ( 110 ) $ 69,173 The following table presents the breakdown of the available-for-sale marketable securities in an unrealized loss position as of June 30, 2023. in thousands June 30, 2023 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 7,952 $ ( 8 ) Total $ 7,952 $ ( 8 ) Corporate debt securities Less than 12 months $ 4,983 $ ( 9 ) Total $ 4,983 $ ( 9 ) in thousands December 31, 2022 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 14,713 $ ( 50 ) Total $ 14,713 $ ( 50 ) Corporate debt securities Less than 12 months $ 16,915 $ ( 57 ) Total $ 16,915 $ ( 57 ) Commercial paper Less than 12 months $ 34,698 $ — Total $ 34,698 $ — Asset backed securities Less than 12 months $ 2,847 $ ( 3 ) Total $ 2,847 $ ( 3 ) The Company does not believe these available-for-sale marketable securities to be other-than-temporarily impaired as of June 30, 2023 . There were no realized gains or losses on available-for-sale marketable securities during the three and six months ended June 30, 2023 and 2022. June 30, 2023 in thousands Amortized Cost Fair Value Due in 1 year or less $ 12,952 $ 12,935 December 31, 2022 in thousands Amortized Cost Fair Value Due in 1 year or less $ 69,283 $ 69,173

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 7. Commitments and Contingencies Legal Proceedings The Company is party to ordinary and routine litigation incidental to its business. On a case-by-case basis, the Company engages inside and outside counsel to assess the probability of potential liability resulting from such litigation. After making such assessments, the Company makes an accrual for the estimated loss only when the loss is probable, and an amount can be reasonably estimated. The Company and or its current or former directors and officers are currently parties to the following litigation matters: On February 9, 2022, a putative class action was filed in the United States District Court for the Eastern District of New York styled Artery v. Astra Space, Inc. et al., Case No. 1:22-cv-00737 (E.D.N.Y.) (the “Artery Action”). On March 23, 2022, a second putative class action was filed in the United States District Court for the Eastern District of New York styled Riley v. Astra Space, Inc., et al., Case No. 1:22-cv-01591 (E.D.N.Y.) (the “Riley Action”). On November 14, 2022, the Artery Action and the Riley Action were consolidated into a single action (the “Securities Action”), restyled In re Astra Space Inc. f/k/a Holicity Inc. Securities Litigation, and Lead Plaintiffs were appointed. On December 14, 2022, the Securities Action was transferred to the United States District Court for the Northern District of California under Case No. 3:22-cv-08875. On December 28, 2022, Lead Plaintiffs filed their amended complaint. The amended complaint alleges that the Company and several of its current and former officers and directors violated provisions of the Securities Exchange Act of 1934 with respect to certain statements concerning the Company’s projected launch cadence and payload capacity goals. The amended complaint seeks unspecified damages on behalf of a purported class of purchasers of the Company’s securities between February 2, 2021 and December 29, 2021. Defendants moved to dismiss on December 28, 2022. See Note 12 - Subsequent Events for developments in the Securities Action occurring after June 30, 2023. On April 27, 2022, a stockholder derivative suit was filed in the United States District Court for the Eastern District of New York styled Gonzalez v. Kemp, et al., Case No. 22-cv-02401 (E.D.N.Y.) (the “Gonzalez Action”). On January 25, 2023, the plaintiff filed an amended complaint. The amended complaint asserts claims against certain of the Company’s current and former officers and directors for alleged breaches of their fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, waste of corporate assets, alleged violations of Section 14(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), and for contribution under Section 10(b) and 21D of the Exchange Act based upon the conduct alleged in the Securities Action described above. The plaintiff in the Gonzalez Action seeks monetary damages in favor of the Company in an unstated amount, reforms to the Company’s corporate governance and internal procedures, restitution including disgorgement of any compensation, profits or other benefits received, and reimbursement of the plaintiff's reasonable fees and costs, including attorney’s fees. On February 17, 2023, the Gonzalez Action was transferred to the United States District Court for the Northern District of California under Case No. 3:23-cv-00713. Defendants filed a motion to dismiss the amended complaint on April 18, 2023. On June 12, 2023, the Court in the Gonzalez Action granted the Company’s motion to stay the case until a final judgment has been issued in the Securities Action. The Company believes that the case is without merit and intends to defend it vigorously. Due to the early stage of the case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. The Company has tendered defense of each of the foregoing claims under its Directors’ and Officers’ policy. The retention under this policy is $ 20.0 million. On or about June 30, 2023 , a stockholder derivative suit was filed in the Delaware Court of Chancery styled Capani v. Chris C. Kemp, et al., C.A. No. 2023-0676- (“Capani Action”). The Capani Action appears to be brought by the same plaintiff who filed the first derivative complaint in the District Court of Delaware in early 2022. The first derivative complaint was voluntarily dismissed without prejudice after the Company filed a motion to dismiss. The stockholder subsequently served a books and records demand before filing the present lawsuit. The Company believes that the case is without merit and intends to defend it vigorously. Due to the early stage of the case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. Indemnification Obligations to former Company Board Members On May 20, 2022, a putative class action was filed in the Court of Chancery of the State of Delaware styled Newbold v. McCaw et. al., Case No. 2022-0439 (the “Newbold Action”). The complaint alleges that Pendrell Corporation, X-icity Holdings Corporation f/k/a Pendrell Holicity Holdings and certain former officers, directors or controlling stockholders of Holicity, Inc. n/k/a Astra Space, Inc., breached their fiduciary duties to the Company in closing on the Business Combination. The complaint seeks unspecified damages on behalf of a purported class of stockholders of the Company’s securities during a specified time period. Neither the Company nor any of its board members are parties in this action. Mr. McCaw, who served as a former member of the Company’s board, is a defendant in this action, but the allegations relate to periods prior to the Business Combination. Astra is obligated to indemnify certain of the defendants in the Newbold Action. The Company has tendered defense of this action under its Directors’ and Officers' Policy. The Company also tendered defense of this claim under the tail policy it was required to purchase in connection with the Business Combination. The retention under the tail policy is $ 1.5 million. Due to the early stage of this case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. See Note 12 – Subsequent Events for information about developments occurring in the Newbold Action after June 30, 2023. Delaware Court of Chancery Approval of Petition relating to Amendment to Increase Authorized Shares On March 1, 2023, the Company filed a petition in the Delaware Court of Chancery (the “Court of Chancery”) seeking validation of the amendment of its certificate of incorporation in connection with the Business Combination to increase its authorized shares of Common Stock (the “Charter Amendment”) as a result of uncertainty regarding the validity of such amendment given a recent decision of the Court of Chancery. On March 14, 2023, the Court of Chancery validated and declared effective the Charter Amendment, increasing the Company’s authorized Common Stock from 220,000,000 to 465,000,000 , thereby permitting the Company to issue additional shares of Class A and Class B common stock in connection with the Business Combination and thereafter. Purchase Commitments In order to reduce manufacturing lead times and to have access to an adequate supply of components, the Company enters into agreements with certain suppliers to procure component inventory based on the Company's production needs. A significant portion of the Company's purchase commitments arising from these agreements consist of firm and non-cancelable commitments. As of June 30, 2023, the Company had $ 27.1 million outstanding purchase commitments whose terms run through May 2026. Payments will be made against these supplier contracts as deliveries occur throughout the term.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2023
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 8 — Stockholders’ Equity Common and Preferred Stock As of June 30, 2023, the Company had authorized a total of 466,000,000 shares of stock, consisting of (i) 400,000,000 shares of Class A common stock, par value $ 0.0001 per share (“Class A common stock”), (ii) 65,000,000 shares of Class B common stock, par value $ 0.0001 per share (“Class B common stock”), and (iii) 1,000,000 shares of preferred stock, par value $ 0.0001 per share (“Preferred Stock”). As of June 30, 2023, the Company had 216,481,966 and 55,539,188 shares of Class A and Class B common stock issued and outstanding, respectively. There were no shares of preferred stock outstanding as of June 30, 2023. Holders of the Class A and Class B common stock have identical distribution rights, except that holders of the Class A common stock are entitled to one vote per share and holders of the Class B common stock are entitled to ten votes per share. Each share of Class B common stock can be converted into one share of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in the Company's amended and restated certificate of incorporation. Reverse Stock Split On June 8, 2023, the Company’s stockholders approved a reverse stock split of all issued and outstanding shares of Class A common stock and Class B common stock (the “Reverse Stock Split”), at a ratio in the range of 1-for-5 to 1-for-15 , with the final decision of whether to proceed with the Reverse Stock Split and the exact ratio and timing of the reverse stock split to be determined by the board of directors, in its discretion, but no later than June 8, 2024. See Note 12 – Subsequent Events for information on developments occurring with respect to the Reverse Stock Split after June 30, 2023. Common Stock Purchase Agreement On August 2, 2022, the Company entered into a Common Stock Purchase Agreement (the "B. Riley Agreement") and a Registration Rights Agreement with B. Riley. Pursuant to the Purchase Agreement, the Company will have the right to sell to B. Riley up to the lesser of (i) $ 100.0 million of newly issued shares (the “Shares”) of the Class A Common Stock, and (ii) 53,059,650 Shares of Class A common stock, which number of shares is equal to 19.99 % of the sum of Class A common stock and Class B common stock issued and outstanding immediately prior to the execution of the B. Riley Purchase Agreement (subject to certain conditions and limitations), from time to time during the term of the B. Riley Purchase Agreement. See Note 12 – Subsequent Events for information regarding the B. Riley Agreement and the Registration Rights Agreement occurring after June 30, 2023.

Stock-based Compensation

Stock-based Compensation	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement	Note 9 — Stock-based Compensation Stock-based incentive awards are provided to employees under the terms of Astra's 2021 Omnibus Incentive Plan (the “2021 Plan”) and 2021 Employee Stock Purchase Plan (the “2021 ESPP”). Under the 2021 Plan, the Company grants restricted stock units (“RSUs”), performance-based stock units ("PSUs"), time-based stock options and performance stock options ("PSOs") to its executive officers. RSUs and time-based stock options granted have service-based vesting conditions only. PSUs granted have service and performance conditions. The service conditions vary for each executive officer and is based on their continued service to the Company. Stock option holders have a 10-year period to exercise their options before options expire. In July 2022, the PSU agreements were amended to remove the performance-based vesting conditions and only retain the time-based vesting condition. Forfeitures are recognized in the period of occurrence and stock-based compensation costs are recognized based on grant-date fair value as RSUs and time-based stock options vest. 2023 Bonus Incentive Plan Under the 2021 Plan, the Board approved the 2023 Bonus Incentive Plan (the "2023 Bonus Plan") on December 12, 2022 for the majority of employees. The 2023 Bonus Plan, in part, provides for performance stock options to be granted to executives, certain key contributors and to the employees. On March 8, 2023, the Company approved the issuance of an aggregate of 5.3 million PSOs under the 2023 Bonus Plan to certain executives and key contributors, which may be earned for such quarter over a two year period based on meeting certain performance conditions. The performance conditions, as further described below, are structured such that the PSOs allocated to each quarter will be earned on a quarterly basis upon the achievement of quarterly Baseline and Stretch Key Performance Indicators ("KPIs") associated with the operations of the Company's Launch Services and Space Products segments. The KPIs are approved by the Compensation Committee at the beginning of each quarter and are communicated to the award holders thereafter, upon such communication establishing the measurement date for that quarter's PSO allocation. The KPIs related to the PSOs allocated to the first and second quarter of 2023 were not communicated to the award holders until May 31, 2023; accordingly, the Company has determined May 31, 2023 as the measurement date for these PSO awards. The Company used the Black-Scholes option pricing-model to calculate the fair value of $ 0.4 million for the first and second quarter PSOs as of May 31, 2023 using the March 8, 2023 closing price based on fair value inputs as of the grant date. As of June 30, 2023, none of the KPIs for the first and second quarter of fiscal year 2023 were achieved. Accordingly, no stock-based compensation expense has been recognized for PSOs allocated to the first and second quarter of 2023 and awards have no intrinsic value as of June 30, 2023 as the awards will be remeasured with the third quarter allocation of the awards and KPIs. The Company has not determined the fair value of the PSO awards allocated to the remainder 2023 and 2024 as the KPIs for those awards have not yet been determined or communicated. As a result, the measurement date of this portion of the award has not been achieved and no stock-based compensation expense has been recognized for the awards to date. Cancellation of Performance Stock Options awards with Service, Performance and Market Conditions On September 20, 2021, under the 2021 Plan, the Company’s Board granted 13,016,178 performance stock options to its executive officers. Of the performance stock options originally granted, only 9,762,133 remained outstanding due to forfeitures occurring in connection with the resignations of former executive officers. The performance stock options were subject to the achievement of the following milestones and the milestones did not need to be achieved in any specific order or sequence: Milestone A: The Company has had a successful orbital delivery. Milestone B: The Company has had six orbital launches during a six consecutive month period. Milestone C: The Company has completed a prototype for a spacecraft that has achieved an orbital launch. Milestone D: The Company has conducted twenty-six orbital launches during a six consecutive month period. Milestone E: The Company has achieved an orbital launch for an aggregate of 100 spacecraft. After a milestone is achieved, twenty percent ( 20 %) of the PSO grant would vest on the vesting date immediately following the date that the volume weighted average share price for a period of thirty trading days has met the share price threshold. For this purpose, a “vesting date” is the February 15, May 15, August 15 or November 15 immediately following the date the share price threshold is achieved and the “share price threshold” is (a) $15.00 following the achievement of the first milestone; (b) $20.00 following the achievement of the second milestone; (c) $30.00 following the achievement of the third milestone; (d) $40.00 following the achievement of the fourth milestone, and (e) $50.00 following the achievement of the fifth milestone. During the second quarter, the Board determined that the performance stock options no longer served the goal of driving financial performance and long-term shareholder value, nor did they serve as retention tools for the Company’s executive officers. Accordingly, the Board recommended cancellation of the PSOs, subject to stockholder approval. On June 8, 2023, stockholders approved the cancellation of the performance stock options and a proposed framework for a replacement award, to be granted to Mr. Kemp, Dr. London and Mr. Attiq before July 31, 2023, subject to the Board’s approval of the final award terms, including any performance conditions. As of August 14, 2023, the Board has not approved replacement awards. As a result of the cancellation of the PSO, without a concurrent replacement award, the cancellation is deemed a settlement of the award with no consideration under ASC 718. As of June 8, 2023, the share price requirements had not been met and on June 8, 2023, the Company assessed the probability of success for the five milestones mentioned above and determined that only Milestone A has been achieved without the share price threshold. As of the date of cancellation, the Company concluded that achievement of Milestone B was not probable as a result of the Company’s decision to focus on its Space Products business. Therefore, the Company reversed all stock-based compensation expense to date of $ 6.8 million associated with Milestone B during the three months ended June 30, 2023 . Additionally, the $ 3.6 million of unrecognized stock-based compensation expense remaining for Milestone B and $ 24.6 million unrecognized stock-compensation expense associated with Milestones C - E were not recognized as stock-based compensation as achievement of the performance conditions was determined to not be probable. The following table summarizes stock-based compensation (benefit) expense that the Company recorded in the unaudited condensed consolidated statements of operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended Six Months Ended in thousands 2023 2022 2023 2022 Cost of revenues $ — $ 456 $ — $ 697 Research and development 1,336 4,832 3,695 11,568 Sales and marketing ( 936 ) 1,417 ( 556 ) 2,997 General and administrative ( 2,512 ) 6,086 77 14,570 Stock-based compensation (benefit) expense $ ( 2,112 ) $ 12,791 $ 3,216 $ 29,832 The Company recognized $ 0.1 million and $ 1.2 million compensation costs related to PSUs for the six months ended June 30, 2023 and 2022, respectively, to reflect the PSUs that satisfied the time-based vesting condition on the time-vesting dates. As of June 30, 2023, the Company had $ 42.6 million of unrecognized stock-based compensation expense related to all of the Company's stock-based awards. This cost is expected to be recognized over a weighted-average period of 3.1 years. Stock Options Awards The following is a summary of stock option activity for the six months ended June 30, 2023: No. of Weighted- Average Exercise Price Weighted- Average Aggregate Intrinsic Outstanding – December 31, 2022 16,248,601 $ 7.11 8.4 $ 9,630 Granted 16,959,558 0.52 8.2 — Exercised 180,923 0.46 0.4 — Forfeited/Cancelled ( 12,154,477 ) 7.41 — — Expired ( 93,082 ) 1.89 — — Outstanding – June 30, 2023 21,141,523 $ 1.64 8.9 $ 64,724 Unvested – June 30, 2023 16,912,151 $ 0.28 9.32 $ 56,754 Exercisable – June 30, 2023 4,229,372 $ 7.07 7.1 $ 7,970 The Company uses the Black-Scholes option pricing-model to calculate the grant date fair value of time-based and performance-based options. The following table summarizes the assumptions used in estimating the fair value of options granted in the six months ended June 30, 2023 and 2022: Six Months Ended 2023 2022 Expected terms (years) (1) 6.7 5.8 Expected volatility (2) 97.2 % 68.9 % Risk-free interest rate (3) 3.5 % 1.7 % Expected dividend rate (4) — — Grant-date fair value $ 0.35 - $ 0.56 $ 3.20 ____________ (1) The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. (2) Expected volatility, or the standard deviation of annualized returns, was calculated based on the Company's common stock price history for the expected term as of the valuation date. (3) Risk-free interest was obtained from U.S. treasury notes for the expected terms noted as of the valuation date . (4) The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future . Restricted Stock Units Awards The following is a summary of restricted stock units for the six months ended June 30, 2023: Number of RSUs Outstanding Weighted- Average Grant Date Fair Value Per Share Outstanding – December 31, 2022 16,121,844 $ 3.35 Granted 990,959 0.52 Vested ( 1,818,269 ) 4.81 Forfeited ( 3,168,829 ) 3.90 Outstanding – June 30, 2023 12,125,705 $ 2.75 Total fair value as of the respective vesting dates of restricted stock units vested for the six months ended June 30, 2023 was approximately $ 0.9 million. As of June 30, 2023, the aggregate intrinsic value of unvested restricted stock units was $ 4.5 million. 2021 ESPP The 2021 ESPP, which is maintained by the Company, allows employees to purchase the Company’s common stock at a discount of up to 15 % of the lesser of the fair market value at the beginning of the offering period or the end of each six-month purchase period. 0.8 million shares were issued under the 2021 ESPP during the six months ended June 30, 2023. As of June 30, 2023, 9.1 million shares remain available for issuance under the 2021 ESPP. As of June 30, 2023, the Company had $ 0.2 million of unrecognized stock-based compensation expense related to the 2021 ESPP. This cost is expected to be recognized over a weighted-average period of 0.76 years.

Loss per Share

Loss per Share	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Loss per Share	Note 10 — Loss per Share The Company computes earnings per share of Common Stock using the two-class method required for participating securities. Basic and diluted earnings per share were the same for the periods presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive. The following tables set forth the computation of basic and diluted loss for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, 2023 2022 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 11,138 ) $ ( 2,866 ) $ ( 65,025 ) $ ( 17,278 ) Basic weighted average common shares outstanding 215,869,537 55,539,188 209,021,924 55,539,188 Dilutive weighted average common shares outstanding 215,869,537 55,539,188 209,021,924 55,539,188 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.05 ) $ ( 0.05 ) $ ( 0.31 ) $ ( 0.31 ) Six months ended June 30, 2023 2022 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 46,819 ) $ ( 12,078 ) $ ( 132,684 ) $ ( 35,332 ) Basic weighted average common shares outstanding 215,288,148 55,539,188 208,569,794 55,539,188 Dilutive weighted average common shares outstanding 215,288,148 55,539,188 208,569,794 55,539,188 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.22 ) $ ( 0.22 ) $ ( 0.64 ) $ ( 0.64 ) There were no preferred dividends declared or accumulated as of June 30, 2023 . The following Class A securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive: June 30, 2023 2022 Stock options 15,879,677 8,166,274 RSUs 12,091,018 15,558,491 Warrants 25,000 — Total 27,995,695 23,724,765 There were no Cla ss B securities that were excluded in the computation of diluted shares outstanding for the three and six months ended June 30, 2023 and 2022 .

Segment Information

Segment Information	6 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Segment Information	Note 11 — Segment Information The Company reports segment information based on a “management” approach to reflect the operating segments for which the Company’s Chief Executive Officer, as the Chief Operating Decision Maker (“CODM”), makes decisions and assesses performance. Prior to the current reporting period, the Company had a single operating and reporting segment. Following commencement of revenue-generating activities for Space Products (as defined below) during the third quarter of fiscal year 2022, the Company restructured the management, operations, and periodic management and internal reporting packages to address the shift in strategy. As a result of these changes, the Company determined that its reporting segments had changed and that beginning in the third quarter of 2022, the Company has two operating and reporting segments: Launch Services and Space Products. The Company recast prior period information related to the change in segments. Launch Services segment provides rapid, global, and affordable launch services to satellite operators and governments. Space Products consist of designing and providing space products based on the customers' needs for a successful satellite launch. The following table shows revenue by reporting segment for the three and six months ended June 30, 2023 and 2022: Three months ended Six months ended in thousands 2023 2022 2023 2022 Revenues: Launch services $ — $ 1,988 $ — $ 5,899 Space products 707 694 707 694 Total revenues: $ 707 $ 2,682 $ 707 $ 6,593 Cost of revenues: Launch services — 17,179 $ — $ 28,193 Space products 388 266 388 266 Total cost of revenues: $ 388 $ 17,445 $ 388 $ 28,459 Gross profit (loss): Launch services $ — $ ( 15,191 ) $ — $ ( 22,294 ) Space products 319 428 319 428 Total gross profit (loss): $ 319 $ ( 14,763 ) $ 319 $ ( 21,866 ) The Company evaluates the performance of its reporting segments based on segment gross profit. Segment gross profit is segment revenue less segment cost of revenue. Unallocated expenses include operating expenses related to research and development, selling and marketing and general and administrative expenses as they are not considered when management evaluates segment performance. The following table reconciles segment gross profit to loss before income taxes for the three and six months ended June 30, 2023 and 2022: Three months ended Six months ended in thousands 2023 2022 2023 2022 Gross profit (loss) $ 319 $ ( 14,763 ) $ 319 $ ( 21,866 ) Research and development 24,395 40,798 55,477 78,725 Selling and marketing 650 4,636 3,134 9,400 General and administrative 7,580 20,608 23,262 41,594 Loss (Gain) on change in fair value of contingent consideration ( 16,625 ) 1,800 ( 19,390 ) 17,300 Interest (income) expense, net ( 384 ) ( 356 ) ( 1,714 ) ( 530 ) Other expense (income), net ( 1,293 ) 54 ( 1,553 ) ( 339 ) Loss before taxes $ ( 14,004 ) $ ( 82,303 ) $ ( 58,897 ) $ ( 168,016 ) The Company does not evaluate performance or allocate resources based on reporting segment’s total assets or operating expenses, and therefore such information is not presented. All of the Company’s long-lived assets are located in the United States. The Company is subject to International Traffic in Arms Regulations (“ITAR”) and generates all of its revenue in the United States.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 12 — Subsequent Events B. Riley Agreement and Registration Rights Agreement Effective July 5, 2023 and in conjunction with the Company entering into the Sales Agreement (defined below), the Company terminated the B Riley Agreement. As of July 5, 2023, B. Riley did not hold any Registrable Securities (as such term is defined in the Registration Rights Agreement). Accordingly, the Company’s obligations under the Registration Rights Agreement were also terminated as of July 5, 2023. Reverse Stock Split On July 6, 2023, the Company’s board of directors approved the Reverse Stock Split at a ratio of (a) one (1) new share of Class A Common Stock for fifteen (15) shares of Class A Common Stock then issued and outstanding; and (b) one (1) new share of Class B Common Stock for fifteen (15) shares of Class B Common Stock then issued and outstanding. The Reverse Stock Split is expected to be consummated on or before October 2, 2023, by the filing of an amendment to the Company’s Second Amended and Restated Certificate of Incorporation. The following pro forma loss shares outstanding and per share is provided to show the effect of the reverse stock split for the periods presented: Three Months Ended June 30, 2023 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 11,138 ) $ ( 2,866 ) $ ( 11,138 ) $ ( 2,866 ) Basic weighted average common shares outstanding 215,869,537 55,539,188 ( 201,478,234 ) ( 51,836,575 ) 14,391,302 3,702,613 Dilutive weighted average common shares outstanding 215,869,537 55,539,188 ( 201,478,234 ) ( 51,836,575 ) 14,391,302 3,702,613 Basic and Diluted loss per share $ ( 0.05 ) $ ( 0.05 ) $ ( 0.72 ) $ ( 0.72 ) $ ( 0.77 ) $ ( 0.77 ) Three Months Ended June 30, 2022 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 65,025 ) $ ( 17,278 ) $ ( 65,025 ) $ ( 17,278 ) Basic weighted average common shares outstanding 209,021,924 55,539,188 ( 195,087,129 ) ( 51,836,575 ) 13,934,795 3,702,613 Dilutive weighted average common shares outstanding 209,021,924 55,539,188 ( 195,087,129 ) ( 51,836,575 ) 13,934,795 3,702,613 Basic and Diluted loss per share $ ( 0.31 ) $ ( 0.31 ) $ ( 4.36 ) $ ( 4.36 ) $ ( 4.67 ) $ ( 4.67 ) Six Months Ended June 30, 2023 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 46,819 ) $ ( 12,078 ) $ ( 46,819 ) $ ( 12,078 ) Basic weighted average common shares outstanding 215,288,148 55,539,188 ( 200,935,605 ) ( 51,836,575 ) 14,352,543 3,702,613 Dilutive weighted average common shares outstanding 215,288,148 55,539,188 ( 200,935,605 ) ( 51,836,575 ) 14,352,543 3,702,613 Basic and Diluted loss per share $ ( 0.22 ) $ ( 0.22 ) $ ( 3.04 ) $ ( 3.04 ) $ ( 3.26 ) $ ( 3.26 ) Six Months Ended June 30, 2022 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 132,684 ) $ ( 35,332 ) $ ( 132,684 ) $ ( 35,332 ) Basic weighted average common shares outstanding 208,569,794 55,539,188 ( 194,665,141 ) ( 51,836,575 ) 13,904,653 3,702,613 Dilutive weighted average common shares outstanding 208,569,794 55,539,188 ( 194,665,141 ) ( 51,836,575 ) 13,904,653 3,702,613 Basic and Diluted loss per share $ ( 0.64 ) $ ( 0.64 ) $ ( 8.90 ) $ ( 8.90 ) $ ( 9.54 ) $ ( 9.54 ) ATM Sales Agreement On July 10, 2023, the Company entered into a Sales Agreement (the “Sales Agreement”) with Roth Capital Partners, LLC ("Roth”). The Sales Agreement provides for the offer and sale of up to $ 65.0 million of the Company’s newly issued Class A common stock, par value $ 0.0001 per share (the “Class A Common Stock”), from time to time through an “at the market offering” program. The Company will specify the parameters for the sale of the shares of Class A common stock, including the number of shares to be issued, the time period during which sales are requested to be made, any limitation on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. The Company may offer and sell up to $ 65.0 million of shares of Class A common stock pursuant to the Sales Agreement; provided however that, until the consummation of the Reverse Stock Split, the Company may only offer and sell 50 million shares of Class A common stock pursuant to the terms of the Sales Agreement. Actual sales of Class A common stock under the Sales Agreement will depend on a variety of factors including, among other things, market conditions and the trading price of the Class A common stock, and the full amount of capital may not be fully realized. The Company intends to use the net proceeds from these at-market offerings, if any, for working capital and general corporate purposes. The Company's general corporate purposes include, but are not limited to, pursuing our growth strategies, continuing the development of our Launch System 2 and expansion of our Astra Spacecraft Engine™ business, capital expenditures, funding strategic investments, working capital and satisfaction of other obligations and other liabilities. The terms of the Securities Purchase Agreement and Notes (both defined and described below) require the Company to maintain an approved at-the-market equity program and/or equity line that, at all times, shall have available and unused capacity to generate at least $ 20.0 million of gross proceeds to the Company, which restriction will limit the Company’s ability to use the full capacity of this Sales Agreement while the Senior Notes (defined below) are outstanding. Newbold Action On or about July 21, 2023 , the Delaware Chancery Court denied the defendants’ motion to dismiss the amended complaint. Securities Action On August 2, 2023, the Company received an order granting its motion to dismiss the amended complaint in the Securities Action. The plaintiffs in this action have a period of 21 days to file an amended complaint. The Company continues to believe that the Securities Action is without merit and intends to defend it vigorously if the plaintiffs timely file an amended complaint. Due to this right and the early stage of the case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. Senior Notes and Warrants Offering Securities Purchase Agreement On August 4, 2023, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor (the “Investor”) pursuant to which the Investor agreed to purchase, and the Company agreed to issue and sell in a registered direct offering to the Investor (the “Offering”), $ 12.5 million aggregate principal amount of senior secured notes (the “Initial Note”) and warrants (the “Initial Warrants”) to purchase up to 22.5 million shares of the Company’s Class A common stock (the “Class A Common Stock” and such shares of Class A Common Stock issuable upon exercise of the Initial Warrants, (the “Warrant Shares”), subject to customary closing conditions. As described in more detail below, subject to the satisfaction of the conditions in the Purchase Agreement, the Company may issue and sell to the Investor up to an additional $ 7.5 million aggregate principal amount of senior secured notes (the “Additional Notes” and, together with the Initial Note, the “Notes”) and warrants (the “Additional Warrants” and, together with the Initial Warrants, the “Warrants”) to purchase the aggregate number of shares of Class A Common Stock equal to 65 % of the aggregate principal amount of the Additional Notes issued divided by the Market Stock Price (as defined in the Notes). The Initial Note bears interest at 9.0 % per annum, mature on November 1, 2024 , and is secured by a first priority security interest in all of the assets of the Company and its subsidiaries. The Initial Warrants are immediately exercisable upon issuance at an exercise price of $ 0.45 per share, subject to certain adjustments, and expire on August 4, 2028. The Securities Purchase Agreement contains customary representations, warranties and agreements by the Company, obligations of the parties, termination provisions and closing conditions. Pursuant to the Securities Purchase Agreement, the Company has agreed to indemnify the Investor against certain liabilities. The representations, warranties and covenants contained in the Securities Purchase Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. The Securities Purchase Agreement also includes certain covenants that, among other things, limit the Company’s ability to issue certain types of securities for specified periods of time. Subject to the satisfaction of the conditions in the Securities Purchase Agreement, the Company may issue and sell to the Investor up to an additional $ 7.5 million aggregate principal amount of Additional Notes (issuable incrementally in up to two separate subsequent closings) and Additional Warrants to purchase the aggregate number of shares of Class A Common Stock equal to 65 % of the aggregate principal amount of the Additional Notes issued divided by the Market Stock Price (as defined in the Notes). Certain of those conditions in the Purchase Agreement include, but are not limited to: (i) the daily VWAP (as defined in the Warrants) of the Class A Common Stock on Nasdaq is not less than $ 1.00 , (ii) after giving pro forma effect to the proposed subsequent closings, the Company’s pro forma indebtedness does not exceed certain specified relative percentages of its market capitalization, (iii) the last funding date under the Securities Purchase Agreement was at least 90 days prior to the proposed subsequent closing, (iv) on the subsequent closing date, the Company will have aggregate capacity to generate gross proceeds of at least $ 20.0 million under an approved at-the-market equity program and/or equity line; and (v) if the Company reports cash and cash equivalents of less than $ 50.0 million at the end of the calendar quarter immediately preceding the date of such Additional Notes purchase, the Company’s Available Cash (as defined in the Purchase Agreement) on the last calendar day of such quarterly period must be greater than or equal to (x) the sum of the Company’s cash and cash equivalents on the last calendar day of the immediately preceding calendar quarter, less (y) $ 10.0 million. No offer to sell Additional Notes to the Investor may occur earlier than two trading days following the Company’s public announcement of its earnings for the fiscal year ended December 31, 2023 and no later than August 4, 2024. The Securities Purchase Agreement also provides that for (i) 60 calendar days after August 4, 2023 and (ii) 45 days after each subsequent closing date pursuant to the Securities Purchase Agreement, the Company and its subsidiaries may not, directly or indirectly, register, offer, sell, grant any option or right to purchase, issue or otherwise dispose of, including make any filing to do the same, any equity or equity-linked securities, subject to limited exceptions, including without limitation, sales pursuant to the Sales Agreement. So long as the Notes are outstanding, the Securities Purchase Agreement provides that the Company may not, directly or indirectly, offer, sell, grant any option to purchase or otherwise dispose of any of its or its subsidiaries’ equity, equity-linked, equity equivalent securities or securities convertible into or exercisable for equity (excluding offerings of Class A Common Stock through an approved at-the-market equity program) unless the Company offers certain participation rights to the holders of the Notes, subject to limited exceptions. So long as any Notes or Warrants are outstanding, the Securities Purchase Agreement also provides that the Company and its subsidiaries may not effect or enter into any “Variable Rate Transactions” (as defined in the Purchase Agreement). Sales of Class A common stock pursuant to an approved at-the-market equity program, including the Sales Agreement, will not be considered Variable Rate Transactions. Notes The Notes will not be issued pursuant to an indenture. The Initial Notes will mature on November 1, 2024 ; provided, that the maturity date may be extended for up to an additional year by written agreement of the Company and the holders thereof. The Notes will bear interest at 9.0 % per annum, which interest rate would increase to 15.0 % per annum upon the existence of an Event of Default (as defined in the Notes) and the Company will be required to make quarterly cash amortization payments. The Notes are be secured by first-priority security interests in all tangible and intangible assets, now owned and hereafter created or acquired, of the Company and its subsidiaries. As additional security for the Notes, the Company is required to maintain a minimum of $ 15 million unrestricted and unencumbered cash and cash equivalents, $ 5 million of which must be deposited in a restricted account, which is not accessible to the Company while the Notes are outstanding. Upon issuance of additional Notes up to the maximum borrowing capacity, the Company will be required to maintain a minimum of $ 20 million unrestricted and unencumbered cash and cash equivalents, $ 8 million of which must be deposited in a restricted account. which is not accessible to the Company while the Notes are outstanding. The Company is also required to maintain an approved at-the-market equity program and/or equity line that, at all times, shall have available and unused capacity to generate at least $ 20.0 million of gross proceeds to the Company, which restriction limits the Company’s ability to use the full capacity of the Sales Agreement. The Company may redeem all (or a portion thereof not less than $ 5.0 million) of the Notes at a price of 105 % of the then-outstanding principal amount at any time. Upon a Fundamental Change (as defined in the Notes), a holder may require the Company to repurchase the Notes at a price equal to 105 % of the aggregate principal amount of the Notes to be repurchased. The Notes impose certain customary affirmative and negative covenants upon the Company, as well as covenants that, among other things, restrict the Company and its subsidiaries from incurring any additional indebtedness or suffering any liens, subject to specified exceptions and restrict the ability of the Company and its subsidiaries from making certain investments, subject to specified exceptions. If an event of default under the Notes occurs, the holders of the Notes can elect to accelerate all amounts due under the Notes for cash equal to 115 % of the then-outstanding principal amount of the Notes, plus accrued and unpaid default interest, which accrues at a rate per annum equal to 15 % from the date of a default or event of default. The Investor purchased the Initial Notes at a discount to their face value for a total purchase price of $ 12.1 million . The Company expects to receive net proceeds of $ 10.8 million , after deducting the placement agent fee and offering expenses. The Company intends to use the proceeds of the Senior Note for working capital and general corporate purposes. Warrants The Initial Warrants are immediately exercisable upon issuance at an exercise price of $ 0.45 per Share, subject to certain adjustments. The exercise price of the Warrants, and the number of Warrant Shares potentially issuable upon exercise of the Warrants, will be adjusted proportionately if the Company subdivides its shares of common stock into a greater number of shares or combines its shares of common stock into a smaller number of shares. In addition, until the earlier to occur of (i) such date as the Company has completed Equity Issuances (as defined in the Warrants) after August 4, 2023 for gross proceeds of at least $ 20.0 million, and (ii) August 4, 2024, if the Company grants, issues or sells or is deemed to have granted, issued or sold, any shares of Class A Common Stock (excluding any Excluded Securities (as defined in the Warrants) for a consideration per share (the “ New Issuance Price ”) less than a price equal to the Warrant exercise price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such Exercise Price then in effect is referred to herein as the “Applicable Price”) (the foregoing a “ Dilutive Issuance ”), then immediately after such Dilutive Issuance, the Warrant exercise price then in effect will be reduced to an amount equal to the New Issuance Price. The Warrants will also be adjusted in connection with the Reverse Stock Split. The Warrants will be recognized as a component of permanent stockholders’ equity within additional paid-in-capital on the condensed consolidated balance sheets and will be recorded at the issuance date using a relative fair value allocation method. The Company has determined the fair value of the Initial Warrants at issuance, which will result in a discount on the Initial Note, and will allocate the proceeds from the offer and sale of the Initial Note proportionately to the Initial Note and to the Initial Warrants, of which $ 4.8 million will be allocated to the Initial Warrants. The Company determined the fair value of the Initial Warrants as of August 4, 2023 using the Black-Scholes option pricing model and applying the following assumptions: Expected terms (years) 5.0 Expected volatility 93.6 % Risk-free interest rate 3.99 % Expected dividend rate — Grant-date fair value $ 0.40 Exercise Price $ 0.45 The Initial Note was issued at 97% of par, resulting in net cash proceeds of $ 12.1 million , after deducting the $ 0.4 million discount fee withheld by the lender and before placement agent fee and offering expenses. In connection with entering into the Initial Note, the Company incurred $ 1.3 million of offering expenses, including agent fees, accounting and legal fees paid directly to the lenders and other direct third-party costs. Total issuance costs also include the fair value of $ 4.8 million of issuance costs. The Company allocated all costs to the Initial Note including lender discount fees, third-party issuance costs and fair value of warrants for an aggregate of $ 6.5 million as unamortized discount, which will be amortized to non-cash interest expense over the term of the Initial Note using the effective interest method. The net proceeds to the Company after deducting lender fees, cash paid to third-parties for issuance costs and the fair value of Warrants will be as follows: in thousands Senior Note Principal $ 12,500 Less: lender original issue discount (1) 375 Net cash proceeds 12,125 Less: cash expenses for third-party issuance costs (1) 1,285 Net proceeds after lender fees and third-party issuance costs 10,840 Less: Discount associated with fair value of Warrants (1) 4,811 Senior Note, net proceeds after lender fees, third-party issuance costs and Warrants $ 6,029 (1) amounts will be accounted for as debt discount and amortized to interest expense over the term of the loan using the effective interest method. The carrying value of the Initial Note will be presented as follows on the Company consolidated balance sheet and will be referred to as the “Senior Note”: in thousands Senior Note $ 12,500 Less: Unamortized debt discount and issuance costs ( 6,471 ) Carrying value of Senior Note $ 6,029 The effective interest rate on the Senior Note, including the discount accretion is expected to approximate 62.45 % as of August 4, 2023. Strategic Restructuring On August 4, 2023, the Company implemented a strategic restructuring of its workforce. The restructuring involved the reallocation of approximately 50 engineering and manufacturing personnel from Launch Services to Space Products. In addition, the Company also announced that it had reduced its overall workforce by approximately 25 % since the beginning of the second quarter, including a reduction of approximately 70 employees on August 4, 2023. The affected employees primarily supported the Company’s launch services, selling, general and administrative and shared services functions and will be paid their base compensation for a period of 60 days consistent with the Company’s normal pay periods.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Astra and its subsidiaries, and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for financial reporting. The condensed consolidated financial statements included herein are unaudited, and reflect all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the periods presented. The condensed consolidated balance sheet data as of December 31, 2022 were derived from Astra’s audited consolidated financial statements included in its 2022 Annual Report. All intercompany transactions and balances have been eliminated in consolidation. The operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 , or for any other future period.
Reclassification	Reclassification Certain prior period amounts have been reclassified to conform to the current period presentation. The impact of these reclassifications was not material to the condensed financial statements for the periods presented.
Liquidity	Liquidity The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these unaudited condensed consolidated financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of ASC Topic 205-40, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern , management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within the control of the Company as of the date the unaudited condensed consolidated financial statements are issued. When substantial doubt exists, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the unaudited condensed consolidated financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The Company evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern over the next twelve months through August 2024. Since inception, the Company has incurred significant operating losses and has an accumulated deficit of approximately $ 1.9 billion . As of June 30, 2023, the Company’s existing sources of liquidity included cash and cash equivalents of $ 13.4 million and marketable securities of $ 12.9 million . The Company believes that its current level of cash and cash equivalents and marketable securities are not sufficient to fund commercial scale production and sale of its services and products. These conditions raise substantial doubt regarding its ability to continue as a going concern for a period of at least one year from the date of issuance of these unaudited condensed consolidated financial statements. In order to proceed with the Company’s business plan, the Company will need to raise substantial additional funds through the issuance of additional debt, equity or both. Until such time, if ever, the Company can generate revenue sufficient to achieve profitability, the Company expects to finance its operations through equity or debt financing, which may not be available to the Company on the timing needed or on terms that the Company deems to be favorable. To the extent that the Company raises additional capital through the sale of equity or convertible debt securities, the ownership interest of its stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting the Company’s ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If the Company is unable to obtain sufficient financial resources, its business, financial condition and results of operations will be materially and adversely affected. The Company may be required to delay, limit, reduce or terminate its product development activities or future commercialization efforts. There can be no assurance that the Company will be able to obtain the needed financing on acceptable terms or at all. In an effort to alleviate these conditions, the Company continues to seek and evaluate opportunities to raise additional capital through the issuance of equity or debt securities. The Company's ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, its performance and investor sentiment with respect to the Company and its industry. See Note 8 – Stockholders’ Equity and Note 12 - Subsequent Events for additional information about financing arrangements entered into since June 30, 2023. As a result of these uncertainties, and notwithstanding management’s plans and efforts to date, there is substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to raise substantial additional capital in the near term, the Company's operations and production plans will be scaled back or curtailed. See Note 12 - Subsequent Events for restructuring activities the Company has implemented since June 30, 2023. If the funds raised are insufficient to provide a bridge to full commercial production at a profit, the Company's operations could be severely curtailed or cease entirely and the Company may not realize any significant value from its assets. The Company has, however, prepared these unaudited condensed consolidated financial statements on a going concern basis, assuming that the Company's financial resources will be sufficient to meet its capital needs over the next twelve months. Accordingly, the Company's financial statements do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should it be unable to continue in operation.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, marketable securities, and accounts receivable. The Company maintains cash and cash equivalent balances in bank accounts with multiple banking partners. All cash accounts are located in the United States (“U.S.”) and insured by the FDIC up to $ 250,000 . Marketable securities consist of highly liquid investments with financial institutions, which management believes to be of a high credit quality. The Company's accounts receivable are derived from revenue earned from customers or invoices billed to customer that represent unconditional right to consideration located within the U.S. The Company mitigates collection risks from its customers by performing regular credit evaluations of the Company's customers’ financial conditions. The Company believes there is no exposure to any significant credit risks related to its cash and cash equivalents or accounts receivable and has not experienced any losses in such accounts. As of June 30, 2023 and December 31, 2022, the following customers accounted for greater than 10 % of the Company's trade accounts receivable: June 30, 2023 December 31, 2022 Customer 1 25.7 % 21.7 % Customer 2 20.7 % 53.3 % Customer 3 16.5 % 20.8 % Customer 4 13.2 % — Customer 5 10.3 % — For the three and six months ended June 30, 2023 and 2022 , the following customers accounted for greater than 10 % of the Company's total revenues: Three Months Ended Six Months Ended 2023 2022 2023 2022 Customer 4 100.0 % — 100 % — Customer 6 — 90.9 % — 84.1 % Customer 7 — (1) — 10.5 % ____________ (1) These customers accounted for less than 10 % of the recognized revenue for the period.
Use of Estimates and Judgements	Use of Estimates and Judgments The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the unaudited condensed consolidated financial statements and accompanying notes. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill and long-lived assets, inventory valuation and reserves, stock-based compensation, pre-combination Astra common stock, useful lives of intangible assets and property, plant and equipment, deferred tax assets, income tax uncertainties, contingent consideration, and other contingencies.
Recently Adopted Accounting Guidance	Recently Adopted Accounting Standards In August 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity , which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. The Company adopted the ASU on January 1, 2023. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows. Recently Issued Accounting Standards Not Yet Adopted In December 2022, the FASB issued ASU No. 2022-06, Reference Rate Reform (Topic 848), Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”). In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provided temporary relief when transitioning from the London Interbank Offered Rate (“LIBOR”) to the Secured Overnight Financing Rate (“SOFR”) or another applicable rate during the original transition period ending on December 31, 2022. In March 2021, the UK Financial Conduct Authority (the “FCA”) announced that the intended cessation date of the overnight 1-, 3-, 6-, and 12-month tenors of U.S. dollar LIBOR would be June 30, 2023, which is beyond the current sunset date of Topic 848. In light of this development, the FASB issued this update to defer the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The Company does not anticipate this new guidance to have a material impact on its financial position, results of operations, cash flows, or related disclosures.

Description of Business, Basis

Description of Business, Basis of Presentation and Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2023
Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net [Abstract]
Schedule of Customers Accounted for Greater than 10% of Trade Accounts Receivable and Total Revenues	As of June 30, 2023 and December 31, 2022, the following customers accounted for greater than 10 % of the Company's trade accounts receivable: June 30, 2023 December 31, 2022 Customer 1 25.7 % 21.7 % Customer 2 20.7 % 53.3 % Customer 3 16.5 % 20.8 % Customer 4 13.2 % — Customer 5 10.3 % — For the three and six months ended June 30, 2023 and 2022 , the following customers accounted for greater than 10 % of the Company's total revenues: Three Months Ended Six Months Ended 2023 2022 2023 2022 Customer 4 100.0 % — 100 % — Customer 6 — 90.9 % — 84.1 % Customer 7 — (1) — 10.5 % ____________ (1) These customers accounted for less than 10 % of the recognized revenue for the period.

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jun. 30, 2023
Revenues [Abstract]
Schedule of Revenue Disaggregated by Type of Revenue	The following table presents revenue disaggregated by type for the periods presented: Three months ended Six Months Ended in thousands 2023 2022 2023 2022 Launch services $ — $ 1,988 $ — $ 5,899 Space products 707 694 707 694 Total revenues $ 707 $ 2,682 $ 707 $ 6,593

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	6 Months Ended
	Jun. 30, 2023
Supplemental Financial Information Abstract
Schedule of Inventory	Inventories in thousands June 30, December 31, Raw materials $ 9,090 $ 2,622 Work in progress 2,141 1,520 Finished goods — — Inventories $ 11,231 $ 4,142
Schedule of Prepaid and Other Current Assets	Prepaid and other current assets in thousands June 30, December 31, Deposits $ 5,592 $ 379 Prepaid license and other prepaid expenses 3,030 3,589 Employee Retention Credit - Payroll Tax 2,101 4,283 Deferred contract costs 3,306 2,446 Other current assets 1,728 2,799 Prepaid and other current assets $ 15,757 $ 13,496
Schedule of Major Classes of Property Plant and Equipment	Property, Plant and Equipment, net Presented in the table below are the major classes of property, plant and equipment: in thousands June 30, December 31, Construction in progress $ 6,703 $ 8,309 Computer and software 2,924 2,810 Leasehold improvements 11,946 10,390 Research equipment 9,031 9,042 Production equipment 20,042 14,100 Furniture and fixtures 500 565 Total property, plant and equipment 51,146 45,216 Less: accumulated depreciation ( 22,845 ) ( 20,945 ) Property, plant and equipment, net $ 28,301 $ 24,271
Schedule of Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities in thousands June 30, December 31, Employee compensation and benefits $ 3,133 $ 5,861 Contract liabilities, current portion 26,511 24,137 Construction in progress related accruals 320 2,692 Professional services 2,787 756 Accrued expenses 3,484 4,423 Accrued inventory purchases 3,110 2,848 Other (miscellaneous) 917 1,326 Accrued expenses and other current liabilities $ 40,262 $ 42,043
Schedule of Other Non-Current Liabilities	Other Non-Current Liabilities in thousands June 30, December 31, Contract liabilities, net of current portion $ 6,605 $ — Other (miscellaneous) 2,024 1,796 Other non-current liabilities $ 8,629 $ 1,796

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Other Intangible Assets	in thousands Carrying Amount Accumulated Amortization Net Book Value June 30, 2023 Definite-lived intangible assets Developed technology $ 9,909 $ ( 3,687 ) $ 6,222 Customer contracts and related relationship 2,383 ( 1,712 ) 671 Trade names 123 ( 123 ) — Intangible assets subject to amortization 12,415 ( 5,522 ) 6,893 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 5,522 ) $ 8,999 in thousands Carrying Amount Accumulated Amortization Net Book Value December 31, 2022 Definite-lived intangible assets Developed technology $ 9,909 $ ( 2,910 ) $ 6,999 Customer contracts and related relationship 2,383 ( 1,376 ) 1,007 Trade names 123 ( 103 ) 20 Intangible assets subject to amortization 12,415 ( 4,389 ) 8,026 Indefinite-lived intangible assets Trademarks 2,106 — 2,106 Total $ 14,521 $ ( 4,389 ) $ 10,132
Expected Future Amortization Expense Related to Intangible Assets	Based on the amount of intangible assets as of June 30, 2023, the expected amortization expense for each of the next five years and thereafter is as follows: in thousands Expected Amortization Expense 2023 (remainder) $ 1,114 2024 1,891 2025 1,555 2026 1,555 2027 778 Total Intangible assets subject to amortization $ 6,893

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of fair value hierarchy	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis: in thousands June 30, 2023 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 327 $ — $ — $ 327 Marketable securities US Treasury securities 7,952 — — 7,952 Corporate debt securities — 4,983 — 4,983 Total financial assets $ 8,279 $ 4,983 $ — $ 13,262 Liabilities: Contingent consideration $ — $ — $ 14,510 $ 14,510 Total financial liabilities $ — $ — $ 14,510 $ 14,510 in thousands December 31, 2022 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 21,909 $ — $ — $ 21,909 Marketable securities US Treasury securities 14,713 — — 14,713 Corporate debt securities — 16,915 — 16,915 Commercial paper — 34,698 — 34,698 Asset backed securities — 2,847 — 2,847 Total financial assets $ 36,622 $ 54,460 $ — $ 91,082 Liabilities: Contingent consideration $ — $ — $ 33,900 $ 33,900 Total financial liabilities $ — $ — $ 33,900 $ 33,900
Summary of the Changes In Fair Value of Financial Instruments	The following table presents a summary of the changes in fair value of the Company's Level 3 financial instruments: in thousands Contingent Consideration Fair value as of December 31, 2022 $ 33,900 Gain on change in fair value of contingent consideration ( 19,390 ) Fair value as of June 30, 2023 $ 14,510 in thousands Contingent Consideration Fair value as of December 31, 2021 $ 13,700 Loss on change in fair value of contingent consideration 17,300 Fair value as of June 30, 2022 $ 31,000
Summary of Range of Inputs To Determine The Fair Value of Contingent Consideration	The following table sets forth the significant assumptions utilized to determine the fair value of contingent consideration as of December 31, 2022: December 31, Risk-free interest rate 4.14 % Expected revenue volatility 19.00 % Revenue discount rate 10.00 % Discount rate 7.50 %
Summary of Available-for-Sale Marketable Securities	The following is a summary of available-for-sale marketable securities as of June 30, 2023 and December 31, 2022: in thousands June 30, 2023 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 7,960 $ ( 8 ) $ 7,952 Corporate debt securities 4,992 ( 9 ) 4,983 Total available-for-sale marketable securities $ 12,952 $ ( 17 ) $ 12,935 in thousands December 31, 2022 Description Amortized Cost Gross Unrealized Loss Fair Value U.S. Treasury securities $ 14,763 $ ( 50 ) $ 14,713 Corporate debt securities 16,972 ( 57 ) 16,915 Commercial paper 34,698 — 34,698 Asset backed securities 2,850 ( 3 ) 2,847 Total available-for-sale marketable securities $ 69,283 $ ( 110 ) $ 69,173
Schedule of Breakdown of the Available-for-Sale Marketable Securities in an Unrealized Loss Position	The following table presents the breakdown of the available-for-sale marketable securities in an unrealized loss position as of June 30, 2023. in thousands June 30, 2023 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 7,952 $ ( 8 ) Total $ 7,952 $ ( 8 ) Corporate debt securities Less than 12 months $ 4,983 $ ( 9 ) Total $ 4,983 $ ( 9 ) in thousands December 31, 2022 Fair Value Gross Unrealized Loss U.S. Treasury securities Less than 12 months $ 14,713 $ ( 50 ) Total $ 14,713 $ ( 50 ) Corporate debt securities Less than 12 months $ 16,915 $ ( 57 ) Total $ 16,915 $ ( 57 ) Commercial paper Less than 12 months $ 34,698 $ — Total $ 34,698 $ — Asset backed securities Less than 12 months $ 2,847 $ ( 3 ) Total $ 2,847 $ ( 3 )
Summary of amortized cost and fair value of available-for-sale securities by contractual maturity	June 30, 2023 in thousands Amortized Cost Fair Value Due in 1 year or less $ 12,952 $ 12,935 December 31, 2022 in thousands Amortized Cost Fair Value Due in 1 year or less $ 69,283 $ 69,173

Stock-based Compensation (Table

Stock-based Compensation (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Share-based Compensation	The following table summarizes stock-based compensation (benefit) expense that the Company recorded in the unaudited condensed consolidated statements of operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended Six Months Ended in thousands 2023 2022 2023 2022 Cost of revenues $ — $ 456 $ — $ 697 Research and development 1,336 4,832 3,695 11,568 Sales and marketing ( 936 ) 1,417 ( 556 ) 2,997 General and administrative ( 2,512 ) 6,086 77 14,570 Stock-based compensation (benefit) expense $ ( 2,112 ) $ 12,791 $ 3,216 $ 29,832
Summary of Stock Option Activity	The following is a summary of stock option activity for the six months ended June 30, 2023: No. of Weighted- Average Exercise Price Weighted- Average Aggregate Intrinsic Outstanding – December 31, 2022 16,248,601 $ 7.11 8.4 $ 9,630 Granted 16,959,558 0.52 8.2 — Exercised 180,923 0.46 0.4 — Forfeited/Cancelled ( 12,154,477 ) 7.41 — — Expired ( 93,082 ) 1.89 — — Outstanding – June 30, 2023 21,141,523 $ 1.64 8.9 $ 64,724 Unvested – June 30, 2023 16,912,151 $ 0.28 9.32 $ 56,754 Exercisable – June 30, 2023 4,229,372 $ 7.07 7.1 $ 7,970 The Company uses the Black-Scholes option pricing-model to calculate the grant date fair value of time-based and performance-based options. The following table summarizes the assumptions used in estimating the fair value of options granted in the six months ended June 30, 2023 and 2022: Six Months Ended 2023 2022 Expected terms (years) (1) 6.7 5.8 Expected volatility (2) 97.2 % 68.9 % Risk-free interest rate (3) 3.5 % 1.7 % Expected dividend rate (4) — — Grant-date fair value $ 0.35 - $ 0.56 $ 3.20 ____________ (1) The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. (2) Expected volatility, or the standard deviation of annualized returns, was calculated based on the Company's common stock price history for the expected term as of the valuation date. (3) Risk-free interest was obtained from U.S. treasury notes for the expected terms noted as of the valuation date . (4) The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future .
Summary of restricted stock units	The following is a summary of restricted stock units for the six months ended June 30, 2023: Number of RSUs Outstanding Weighted- Average Grant Date Fair Value Per Share Outstanding – December 31, 2022 16,121,844 $ 3.35 Granted 990,959 0.52 Vested ( 1,818,269 ) 4.81 Forfeited ( 3,168,829 ) 3.90 Outstanding – June 30, 2023 12,125,705 $ 2.75

Loss per Share (Tables)

Loss per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Loss	The following tables set forth the computation of basic and diluted loss for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, 2023 2022 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 11,138 ) $ ( 2,866 ) $ ( 65,025 ) $ ( 17,278 ) Basic weighted average common shares outstanding 215,869,537 55,539,188 209,021,924 55,539,188 Dilutive weighted average common shares outstanding 215,869,537 55,539,188 209,021,924 55,539,188 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.05 ) $ ( 0.05 ) $ ( 0.31 ) $ ( 0.31 ) Six months ended June 30, 2023 2022 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 46,819 ) $ ( 12,078 ) $ ( 132,684 ) $ ( 35,332 ) Basic weighted average common shares outstanding 215,288,148 55,539,188 208,569,794 55,539,188 Dilutive weighted average common shares outstanding 215,288,148 55,539,188 208,569,794 55,539,188 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.22 ) $ ( 0.22 ) $ ( 0.64 ) $ ( 0.64 )
Schedule of Antidilutive Shares	The following Class A securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive: June 30, 2023 2022 Stock options 15,879,677 8,166,274 RSUs 12,091,018 15,558,491 Warrants 25,000 — Total 27,995,695 23,724,765 There were no Cla ss B securities that were excluded in the computation of diluted shares outstanding for the three and six months ended June 30, 2023 and 2022 .

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Schedule of Revenue by Reportable Segment	The following table shows revenue by reporting segment for the three and six months ended June 30, 2023 and 2022: Three months ended Six months ended in thousands 2023 2022 2023 2022 Revenues: Launch services $ — $ 1,988 $ — $ 5,899 Space products 707 694 707 694 Total revenues: $ 707 $ 2,682 $ 707 $ 6,593 Cost of revenues: Launch services — 17,179 $ — $ 28,193 Space products 388 266 388 266 Total cost of revenues: $ 388 $ 17,445 $ 388 $ 28,459 Gross profit (loss): Launch services $ — $ ( 15,191 ) $ — $ ( 22,294 ) Space products 319 428 319 428 Total gross profit (loss): $ 319 $ ( 14,763 ) $ 319 $ ( 21,866 )
Summary of Reconciles Segment Gross Profit to Loss Before Income Taxes	The following table reconciles segment gross profit to loss before income taxes for the three and six months ended June 30, 2023 and 2022: Three months ended Six months ended in thousands 2023 2022 2023 2022 Gross profit (loss) $ 319 $ ( 14,763 ) $ 319 $ ( 21,866 ) Research and development 24,395 40,798 55,477 78,725 Selling and marketing 650 4,636 3,134 9,400 General and administrative 7,580 20,608 23,262 41,594 Loss (Gain) on change in fair value of contingent consideration ( 16,625 ) 1,800 ( 19,390 ) 17,300 Interest (income) expense, net ( 384 ) ( 356 ) ( 1,714 ) ( 530 ) Other expense (income), net ( 1,293 ) 54 ( 1,553 ) ( 339 ) Loss before taxes $ ( 14,004 ) $ ( 82,303 ) $ ( 58,897 ) $ ( 168,016 )

Subsequent Events (Tables)

Subsequent Events (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Pro Forma Loss Shares Outstanding and Per Share	The following pro forma loss shares outstanding and per share is provided to show the effect of the reverse stock split for the periods presented: Three Months Ended June 30, 2023 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 11,138 ) $ ( 2,866 ) $ ( 11,138 ) $ ( 2,866 ) Basic weighted average common shares outstanding 215,869,537 55,539,188 ( 201,478,234 ) ( 51,836,575 ) 14,391,302 3,702,613 Dilutive weighted average common shares outstanding 215,869,537 55,539,188 ( 201,478,234 ) ( 51,836,575 ) 14,391,302 3,702,613 Basic and Diluted loss per share $ ( 0.05 ) $ ( 0.05 ) $ ( 0.72 ) $ ( 0.72 ) $ ( 0.77 ) $ ( 0.77 ) Three Months Ended June 30, 2022 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 65,025 ) $ ( 17,278 ) $ ( 65,025 ) $ ( 17,278 ) Basic weighted average common shares outstanding 209,021,924 55,539,188 ( 195,087,129 ) ( 51,836,575 ) 13,934,795 3,702,613 Dilutive weighted average common shares outstanding 209,021,924 55,539,188 ( 195,087,129 ) ( 51,836,575 ) 13,934,795 3,702,613 Basic and Diluted loss per share $ ( 0.31 ) $ ( 0.31 ) $ ( 4.36 ) $ ( 4.36 ) $ ( 4.67 ) $ ( 4.67 ) Six Months Ended June 30, 2023 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 46,819 ) $ ( 12,078 ) $ ( 46,819 ) $ ( 12,078 ) Basic weighted average common shares outstanding 215,288,148 55,539,188 ( 200,935,605 ) ( 51,836,575 ) 14,352,543 3,702,613 Dilutive weighted average common shares outstanding 215,288,148 55,539,188 ( 200,935,605 ) ( 51,836,575 ) 14,352,543 3,702,613 Basic and Diluted loss per share $ ( 0.22 ) $ ( 0.22 ) $ ( 3.04 ) $ ( 3.04 ) $ ( 3.26 ) $ ( 3.26 ) Six Months Ended June 30, 2022 As Reported Impact of Reverse Stock Split Revised Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Class A Common Stock Class B Common Stock Net loss attributed to common stockholders $ ( 132,684 ) $ ( 35,332 ) $ ( 132,684 ) $ ( 35,332 ) Basic weighted average common shares outstanding 208,569,794 55,539,188 ( 194,665,141 ) ( 51,836,575 ) 13,904,653 3,702,613 Dilutive weighted average common shares outstanding 208,569,794 55,539,188 ( 194,665,141 ) ( 51,836,575 ) 13,904,653 3,702,613 Basic and Diluted loss per share $ ( 0.64 ) $ ( 0.64 ) $ ( 8.90 ) $ ( 8.90 ) $ ( 9.54 ) $ ( 9.54 )
Summary of Net Proceeds After Deducting Issuance Costs and Fair Value	The net proceeds to the Company after deducting lender fees, cash paid to third-parties for issuance costs and the fair value of Warrants will be as follows: in thousands Senior Note Principal $ 12,500 Less: lender original issue discount (1) 375 Net cash proceeds 12,125 Less: cash expenses for third-party issuance costs (1) 1,285 Net proceeds after lender fees and third-party issuance costs 10,840 Less: Discount associated with fair value of Warrants (1) 4,811 Senior Note, net proceeds after lender fees, third-party issuance costs and Warrants $ 6,029 (1) amounts will be accounted for as debt discount and amortized to interest expense over the term of the loan using the effective interest method.
Summary of Carrying Value of Initial Note	The carrying value of the Initial Note will be presented as follows on the Company consolidated balance sheet and will be referred to as the “Senior Note”: in thousands Senior Note $ 12,500 Less: Unamortized debt discount and issuance costs ( 6,471 ) Carrying value of Senior Note $ 6,029
Letter of Credit [Member] | Senior Notes [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Fair Value of Initial Warrants Using Black-Scholes Option Pricing Model	The Company determined the fair value of the Initial Warrants as of August 4, 2023 using the Black-Scholes option pricing model and applying the following assumptions: Expected terms (years) 5.0 Expected volatility 93.6 % Risk-free interest rate 3.99 % Expected dividend rate — Grant-date fair value $ 0.40 Exercise Price $ 0.45

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Additional information (Details)	6 Months Ended		9 Months Ended
	Jun. 30, 2023 USD ($) Segment	Jun. 30, 2022 Segment	Sep. 30, 2022 Segment	Dec. 31, 2022 USD ($)
Accounting Policy [Line Items]
Number of operating and reportable segments | Segment		1	2
Cash and cash equivalents	$ 13,384,000			$ 33,644,000
Marketable securities	12,900,000
Accumulated deficit	(1,878,718,000)			$ (1,819,821,000)
Maximum [Member]
Accounting Policy [Line Items]
Cash, FDIC insured amount	$ 250,000
Launch Services [Member]
Accounting Policy [Line Items]
Number of operating and reportable segments | Segment	2
Space Products [Member]
Accounting Policy [Line Items]
Number of operating and reportable segments | Segment	2

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Customers Accounted for Greater than 10% of Trade Accounts Receivable and Total Revenues (Details) - Customer [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Customer 1 [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			25.70%		21.70%
Customer 2 [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			20.70%		53.30%
Customer 3 [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			16.50%		20.80%
Customer 4 [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			13.20%		0%
Customer 4 [Member] | Revenue [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage	100%	0%	100%	0%
Customer 5 [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			10.30%		0%
Customer 6 [Member] | Revenue [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage	0%	90.90%	0%	84.10%
Customer 7 [Member] | Revenue [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage	0%		0%	10.50%

Basis of Presentation and Sum_5

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Customers Accounted for Greater than 10% of Trade Accounts Receivable and Total Revenues (Parenthetical) (Details) - Customer [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Accounts Receivable [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			10%		10%
Revenue [Member] | Maximum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage	10%	10%	10%	10%
Revenue [Member] | Minimum [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Concentration risk percentage			10%

Revenues - Schedule of Revenue

Revenues - Schedule of Revenue Disaggregated by Type of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 707	$ 2,682	$ 707	$ 6,593
Launch Services [Member]
Disaggregation of Revenue [Line Items]
Total revenues	0	1,988	0	5,899
Space Products [Member]
Disaggregation of Revenue [Line Items]
Total revenues	$ 707	$ 694	$ 707	$ 694

Revenues - Additional Informati

Revenues - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Revenues [Abstract]
Contract asset			$ 3.3		$ 2.4
Contract liabilities	$ 33.1		33.1		$ 24.1
Revenue	0.7	$ 2.7	0.7	$ 4.9
Other income (expense), net	$ 1.5	$ 0	$ 1.5	$ 0.4

Revenues - Additional Informa_2

Revenues - Additional Information (Details 1) $ in Millions	Jun. 30, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 46
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 95.2
Expected timing of performance obligation satisfaction, period	6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 49.2
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 49.2
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 49.2
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Unsatisfied performance obligations	$ 49.2
Expected timing of performance obligation satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of performance obligation satisfaction, period	1 year

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Business Combination Segment Allocation [Line Items]
Decrease in fair value of contingent consideration liability			$ 19,390	$ (17,300)
Cash and Cash Equivalents, Period Increase (Decrease)			(20,260)	(220,692)
Loss (Gain) on change in fair value of contingent consideration			(19,390)	17,300
General and administrative expenses	$ 7,580	$ 20,608	23,262	$ 41,594
Additional paid in capital	$ 1,905,870		$ 1,905,870		$ 1,902,213
Common Class A [Member]
Business Combination Segment Allocation [Line Items]
Common stock, shares issued	216,481,966		216,481,966		216,481,966
Common stock, shares outstanding	213,697,468		213,697,468		213,697,468
Common stock, par value	$ 0.0001		$ 0.0001		$ 0.0001
Common Class B [Member]
Business Combination Segment Allocation [Line Items]
Common stock, shares issued	55,539,188		55,539,188		55,539,188
Common stock, shares outstanding	55,539,188		55,539,188		55,539,188
Common stock, par value	$ 0.0001		$ 0.0001		$ 0.0001

Supplemental Financial Inform_3

Supplemental Financial Information - Schedule of Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Supplemental Financial Information Abstract
Raw materials	$ 9,090	$ 2,622
Work in progress	2,141	1,520
Finished goods	0	0
Inventories, net	$ 11,231	$ 4,142

Supplemental Financial Inform_4

Supplemental Financial Information - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Property Plant And Equipment [Line Items]
Depreciation	$ 1,100	$ 4,000	$ 1,900	$ 6,004
Inventory write-downs	0	13,300	0	18,828
Inventory write-down related to discontinuance of production			10,200
Impairment charges	$ 0	$ 0	$ 0	$ 0

Supplemental Financial Inform_5

Supplemental Financial Information - Schedule of Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Prepaid Expense and Other Assets, Current [Abstract]
Deposits	$ 5,592	$ 379
Prepaid license and other prepaid expenses	3,030	3,589
Employee Retention Credit - Payroll Tax	2,101	4,283
Contract assets	3,306	2,446
Other current assets	1,728	2,799
Prepaid and other current assets	$ 15,757	$ 13,496

Supplemental Financial Inform_6

Supplemental Financial Information - Schedule of Major Classes of Property Plant and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 51,146	$ 45,216
Less: accumulated depreciation	(22,845)	(20,945)
Property, plant and equipment, net	28,301	24,271
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	6,703	8,309
Computer and Software [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	2,924	2,810
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	11,946	10,390
Research Equipment [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	9,031	9,042
Production Equipment [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	20,042	14,100
Furniture and Fixtures [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 500	$ 565

Supplemental Financial Inform_7

Supplemental Financial Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Other Liabilities, Current [Abstract]
Employee compensation and benefits	$ 3,133	$ 5,861
Contract liabilities, current portion	26,511	24,137
Construction in progress related accruals	320	2,692
Professional services	2,787	756
Accrued expenses	3,484	4,423
Accrued inventory purchases	3,110	2,848
Other (miscellaneous)	917	1,326
Accrued expenses and other current liabilities	$ 40,262	$ 42,043

Supplemental Financial Inform_8

Supplemental Financial Information - Schedule of Other Non Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accrued Liabilities and Other Liabilities [Abstract]
Contract liabilities, net of current portion	$ 6,605	$ 0
Other (miscellaneous)	2,024	1,796
Other non-current liabilities	$ 8,629	$ 1,796

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Asset Impairment Charges	$ 0	$ 0	$ 0	$ 0
Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Asset Impairment Charges	$ 0	$ 0	$ 0	$ 0

Intangible Assets - Summary of

Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	$ 12,415	$ 12,415
Intangible assets accumulated amortization	(5,522)	4,389
Intangible assets subject to amortization, accumulated amortization	(5,522)	4,389
Total intangible assets	6,893	8,026
Total intangible assets, Carrying amount	14,521	14,521
Total intangible assets	8,999	10,132
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Carrying amount	2,106	2,106
Infinite lived intangible assets accumulated amortization	0	0
Total intangible assets	2,106	2,106
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	9,909	9,909
Intangible assets subject to amortization, accumulated amortization	(3,687)	2,910
Total intangible assets	6,222	6,999
Customer Contracts And Related Relationship [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	2,383	2,383
Intangible assets subject to amortization, accumulated amortization	(1,712)	1,376
Total intangible assets	671	1,007
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross	123	123
Intangible assets subject to amortization, accumulated amortization	(123)	103
Total intangible assets	$ 0	$ 20

Intangible Assets - Expected Fu

Intangible Assets - Expected Future Amortization Expense Related to Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remainder)	$ 1,114
2024	1,891
2025	1,555
2026	1,555
2027	778
Total intangible assets	$ 6,893	$ 8,026

Warrant Liabilities - Additiona

Warrant Liabilities - Additional Information (Details) - shares	Jun. 30, 2023	Dec. 31, 2022
Common Class A [Member]
Class of Warrant or Right [Line Items]
Common stock, shares issued	216,481,966	216,481,966

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Aug. 16, 2022
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	$ 0	$ 0	$ 0	$ 0
Percent of minimum tax on book income					15%
Percent of excise tax on net stock repurchases					1%

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of fair value hierarchy (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Assets:
Total financial assets	$ 13,262	$ 91,082
Liabilities:
Total financial liabilities	14,510	33,900
Contingent Consideration [Member]
Liabilities:
Total financial liabilities	$ 14,510	$ 33,900
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Liabilities	Liabilities
Level 1 [Member]
Assets:
Total financial assets	$ 8,279	$ 36,622
Liabilities:
Total financial liabilities	0	0
Level 1 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	0	0
Level 2 [Member]
Assets:
Total financial assets	4,983	54,460
Liabilities:
Total financial liabilities	0	0
Level 2 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	0	0
Level 3 [Member]
Assets:
Total financial assets	0	0
Liabilities:
Total financial liabilities	14,510	33,900
Level 3 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	14,510	33,900
Money market account
Assets:
Total financial assets	327	21,909
Money market account | Level 1 [Member]
Assets:
Total financial assets	327	21,909
Money market account | Level 2 [Member]
Assets:
Total financial assets	0	0
Money market account | Level 3 [Member]
Assets:
Total financial assets	0	0
US Treasury securities
Assets:
Total financial assets	7,952	14,713
US Treasury securities | Level 1 [Member]
Assets:
Total financial assets	7,952	14,713
US Treasury securities | Level 2 [Member]
Assets:
Total financial assets	0	0
US Treasury securities | Level 3 [Member]
Assets:
Total financial assets	0	0
Corporate debt securities
Assets:
Total financial assets	4,983	16,915
Corporate debt securities | Level 1 [Member]
Assets:
Total financial assets	0	0
Corporate debt securities | Level 2 [Member]
Assets:
Total financial assets	4,983	16,915
Corporate debt securities | Level 3 [Member]
Assets:
Total financial assets	$ 0	0
Commercial paper
Assets:
Total financial assets		34,698
Commercial paper | Level 1 [Member]
Assets:
Total financial assets		0
Commercial paper | Level 2 [Member]
Assets:
Total financial assets		34,698
Commercial paper | Level 3 [Member]
Assets:
Total financial assets		0
Asset backed securities
Assets:
Total financial assets		$ 2,847
Derivative Asset, Statement of Financial Position [Extensible Enumeration]		Assets
Asset backed securities | Level 1 [Member]
Assets:
Total financial assets		$ 0
Asset backed securities | Level 2 [Member]
Assets:
Total financial assets		2,847
Asset backed securities | Level 3 [Member]
Assets:
Total financial assets		$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of the Changes In Fair Value of the Company Financial Instruments (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair value , Beginning balance	$ 33,900	$ 13,700
Gain on change in fair value of contingent consideration	(19,390)	17,300
Fair value , Ending balance	$ 14,510	$ 31,000

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Range of Inputs To Determine The fair Value of Contingent Consideration (Details)	Dec. 31, 2022
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	4.14
Expected revenue volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	19
Revenue discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	10
Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	7.50

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 12,952	$ 69,283
Gross Unrealized Loss	(17)	(110)
Fair Value	12,935	69,173
US Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	7,960	14,763
Gross Unrealized Loss	(8)	(50)
Fair Value	7,952	14,713
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	4,992	16,972
Gross Unrealized Loss	(9)	(57)
Fair Value	$ 4,983	16,915
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost		34,698
Gross Unrealized Loss		0
Fair Value		34,698
Asset backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost		2,850
Gross Unrealized Loss		(3)
Fair Value		$ 2,847

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Breakdown of the Available-for-Sale Marketable Securities in an Unrealized Loss Position (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
US Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months	$ 7,952	$ 14,713
Fair Value, Total	7,952	14,713
Gross Unrealized Loss, Less than 12 months	(8)	(50)
Gross Unrealized Loss, Total	(8)	(50)
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months	4,983	16,915
Fair Value, Total	4,983	16,915
Gross Unrealized Loss, Less than 12 months	(9)	(57)
Gross Unrealized Loss, Total	$ (9)	(57)
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months		34,698
Fair Value, Total		34,698
Gross Unrealized Loss, Less than 12 months		0
Gross Unrealized Loss, Total		0
Asset backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Less than 12 months		2,847
Fair Value, Total		2,847
Gross Unrealized Loss, Less than 12 months		(3)
Gross Unrealized Loss, Total		$ (3)

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain (loss) on available-for-sale marketable securities	$ 0	$ 0	$ 0	$ 0

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Gains or Losses on Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Amortized Cost, Due in 1 year or less	$ 12,952	$ 69,283
Fair Value, Due in 1 year or less	$ 12,935	$ 69,173

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Mar. 14, 2023	May 20, 2022	Apr. 27, 2022
Retention costs payable			$ 1.5	$ 20
Common stock, shares authorized	466,000,000
Outstanding purchase commitments	$ 27.1
Stockholder derivative suit filed date	June 30, 2023
Maximum [Member]
Common stock, shares authorized		465,000,000
Minimum [Member]
Common stock, shares authorized		220,000,000

Convertible Preferred Stock - A

Convertible Preferred Stock - Additional Information (Details)	Jun. 30, 2023 shares
Preferred stock, shares outstanding	0

Convertible Preferred Stock - S

Convertible Preferred Stock - Schedule of Three Classes of Convertible Preferred Stock Before Combination (Details)	Jun. 30, 2023 shares
Preferred stock, shares outstanding	0

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			6 Months Ended
	Jun. 08, 2023	Aug. 02, 2022	Jun. 30, 2023	Dec. 31, 2022
Common stock, shares authorized			466,000,000
Preferred stock, shares outstanding			0
Reverse Stock Split description			On July 6, 2023, the Company’s board of directors approved the Reverse Stock Split at a ratio of (a) one (1) new share of Class A Common Stock for fifteen (15) shares of Class A Common Stock then issued and outstanding; and (b) one (1) new share of Class B Common Stock for fifteen (15) shares of Class B Common Stock then issued and outstanding. The Reverse Stock Split is expected to be consummated on or before October 2, 2023, by the filing of an amendment to the Company’s Second Amended and Restated Certificate of Incorporation.
Common Class A [Member]
Common stock, shares authorized			400,000,000	400,000,000
Common stock, par value			$ 0.0001	$ 0.0001
Common stock, shares issued			216,481,966	216,481,966
Common Class A [Member] | B. Riley Principal Capital II, LLC [Member] | Purchase Agreement And Registration Rights Agreement [Member]
Newly issued shares, value		$ 100
Common Class B [Member]
Common stock, shares authorized			65,000,000	65,000,000
Common stock, par value			$ 0.0001	$ 0.0001
Common stock, shares issued			55,539,188	55,539,188
Preferred Stock [Member]
Preferred stock, shares outstanding			0	0
Preference shares authorized			1,000,000	1,000,000
Preference shares, par value (in Dollars per share)			$ 0.0001	$ 0.0001
Class A and Class B Common Stock [Member]
Reverse Stock Split description	1-for-5 to 1-for-15
Class A and Class B Common Stock [Member] | B. Riley Principal Capital II, LLC [Member] | Purchase Agreement And Registration Rights Agreement [Member]
Newly issued shares		53,059,650
Number of shares, percentage		19.99%

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details) - USD ($) $ in Thousands			3 Months Ended		6 Months Ended
	Mar. 08, 2023	Sep. 20, 2021	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense			$ (2,112)	$ 12,791	$ 3,216	$ 29,832
Award granted					16,959,558
Award Forfieted					12,154,477
Unvested aggregate intrinsic value			56,754		$ 56,754
Stock-Based Awards [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Weighted average period expected to be recognized					3 years 1 month 6 days
Unrecognized Stock Based Compensation Expense					$ 42,600
Restricted Stock Units (RSUs) [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total fair value as of the respective vesting dates of restricted stock units vested					900
Unvested aggregate intrinsic value			4,500		$ 4,500
Performance Based Stock Option [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Vesting Percentage					20%
PSUs [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Compensation cost					$ 100	1,200
Executive Officer | Performance Based Stock Option [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award granted		13,016,178
Award Forfieted		9,762,133
General and Administrative Expense [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense			$ (2,512)	$ 6,086	77	$ 14,570
2021 Employee Stock Purchase Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Remain available for issuance					$ 9,100
Discount on Shares Purchased							15%
Shares Issued			800,000		800,000
Unrecognized Stock Based Compensation Expense					$ 200
Cost Over Weighted Average Period					9 months 3 days
2023 Bonus Incentive Plan [Member] | Performance Based Stock Option [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Remain available for issuance	$ 5,300
Milestones B
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense			$ 6,800
Unrecognized Stock Based Compensation Expense					$ 3,600
Milestones C
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Unrecognized Stock Based Compensation Expense					$ 24,600

Stock-based Compensation - Summ

Stock-based Compensation - Summary of Share-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ (2,112)	$ 12,791	$ 3,216	$ 29,832
Cost of revenues [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	0	456	0	697
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	1,336	4,832	3,695	11,568
Sales and Marketing [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	(936)	1,417	(556)	2,997
General and Administrative [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ (2,512)	$ 6,086	$ 77	$ 14,570

Stock-based Compensation - Su_2

Stock-based Compensation - Summary of stock option activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Options outstanding Beginning balance, Shares	16,248,601
Options outstanding, Granted	16,959,558
Options outstanding, Exercised	180,923
Options outstanding, Forfeited/Cancelled	(12,154,477)
Options outstanding, Expired	(93,082)
Options Outstanding, Ending balance, Shares	21,141,523	16,248,601
Unvested, Ending balance	16,912,151
Exercisable, Ending balance	4,229,372
Options outstanding Beginning balance, Shares	$ 7.11
Options outstanding, Granted	0.52
Options Outstanding, Exercised	0.46
Options outstanding, Forfeited/Cancelled	7.41
Options outstanding, Expired	1.89
Options Outstanding, Ending balance, Shares	1.64	$ 7.11
Weighted- Average Exercise Price - Unvested	0.28
Exercisable - June 30, 2023	$ 7.07
Weighted average remaining term, outstanding	8 years 10 months 24 days	8 years 4 months 24 days
Weighted average remaining term, exercised	4 months 24 days
Weighted Average Remaining Term Granted	8 years 2 months 12 days
Weighted- Average Remaining Term Unvested	9 years 3 months 25 days
Weighted Average Remaining Term, Exercisable	7 years 1 month 6 days
Outstanding aggregate intrinsic value, Beginning balance	$ 9,630
Outstanding aggregate intrinsic value, Ending balance	64,724	$ 9,630
Unvested aggregate intrinsic value	56,754
Exercisable June 30, 2023	$ 7,970

Stock-based Compensation - Su_3

Stock-based Compensation - Summary of fair value of options granted (Details) - $ / shares		6 Months Ended
		Jun. 30, 2023	Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant-date fair value		$ 0.4
Time Based Options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected terms (years)	[1]	6 years 8 months 12 days	5 years 9 months 18 days
Expected volatility	[2]	97.20%	68.90%
Risk-free interest rate	[3]	3.50%	1.70%
Expected dividend rate	[4]	0%	0%
Grant-date fair value			$ 3.20
Time Based Options | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant-date fair value		$ 0.35
Time Based Options | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant-date fair value		$ 0.56
[1] The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. Expected volatility, or the standard deviation of annualized returns, was calculated based on the Company's common stock price history for the expected term as of the valuation date. Risk-free interest was obtained from U.S. treasury notes for the expected terms noted as of the valuation date The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future

Stock-based Compensation - Su_4

Stock-based Compensation - Summary of restricted stock units (Details)	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant-date fair value	$ 0.4
RSUs [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning balance | shares	16,121,844
Number of RSUs Outstanding Granted | shares	990,959
Number of RSUs Outstanding, Vested | shares	(1,818,269)
Number of RSUs Outstanding, Forfeited | shares	(3,168,829)
Outstanding, ending balance | shares	12,125,705
Weighted- Average Grant Date Fair Value Per Share, Beginning balance	$ 3.35
Grant-date fair value	0.52
Weighted Average Grant Date Fair Value Per Share, Vested	4.81
Weighted Average Grant Date Fair Value Per Share, Forfeited	3.90
Weighted- Average Grant Date Fair Value Per Share, Ending balance	$ 2.75

Loss per Share - Schedule of Co

Loss per Share - Schedule of Computation of Basic and Diluted Loss (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Common Class A [Member]
Net loss attributed to common stockholders	$ (11,138)	$ (65,025)	$ (46,819)	$ (132,684)
Basic weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Dilutive weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Common Class B [Member]
Net loss attributed to common stockholders	$ (2,866)	$ (17,278)	$ (12,078)	$ (35,332)
Basic weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188
Dilutive weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)

Loss per Share - Additional Inf

Loss per Share - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Earnings Per Share [Abstract]
Preferred dividends declared			$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0	0	0

Loss per Share - Schedule of _2

Loss per Share - Schedule of Computation of diluted Shares Outstanding (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	0	0	0
Common Class A [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total			27,995,695	23,724,765
Common Class A [Member] | RSUs [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total			12,091,018	15,558,491
Common Class A [Member] | Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total			15,879,677	8,166,274
Common Class A [Member] | Warrant [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total			25,000	0

Segment Information - Schedule

Segment Information - Schedule of Segment Reporting Information by Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 707	$ 2,682	$ 707	$ 6,593
Total cost of revenues	388	17,445	388	28,459
Total gross profit (loss)	319	(14,763)	319	(21,866)
Launch Services [Member]
Segment Reporting Information [Line Items]
Total revenues	0	1,988	0	5,899
Total cost of revenues	0	17,179	0	28,193
Total gross profit (loss)	0	(15,191)	0	(22,294)
Space Products [Member]
Segment Reporting Information [Line Items]
Total revenues	707	694	707	694
Total cost of revenues	388	266	388	266
Total gross profit (loss)	$ 319	$ 428	$ 319	$ 428

Segment Information - Summary o

Segment Information - Summary of Reconciles Segment Gross Profit to Loss Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting [Abstract]
Gross profit (loss)	$ 319	$ (14,763)	$ 319	$ (21,866)
Research and development	24,395	40,798	55,477	78,725
Selling and marketing	650	4,636	3,134	9,400
General and administrative	7,580	20,608	23,262	41,594
Loss (Gain) on change in fair value of contingent consideration	(16,625)	1,800	(19,390)	17,300
Interest (income) expense, net	(384)	(356)	(1,714)	(530)
Other expense (income), net	(1,293)	54	(1,553)	(339)
Loss before taxes	$ (14,004)	$ (82,303)	$ (58,897)	$ (168,016)

Segment Information - Additiona

Segment Information - Additional Information (Details) - Segment	6 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022
Segment Reporting Information [Line Items]
Number of Operating and Reportable Segments		1	2
Launch Services [Member]
Segment Reporting Information [Line Items]
Number of Operating and Reportable Segments	2
Space Products [Member]
Segment Reporting Information [Line Items]
Number of Operating and Reportable Segments	2

Subsequent Events - Schedule of

Subsequent Events - Schedule of Pro Forma Loss Shares Outstanding and Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Common Class A [Member]
Net loss attributed to common stockholders	$ (11,138)	$ (65,025)	$ (46,819)	$ (132,684)
Basic weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Dilutive weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Loss per share, basic	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Loss per share, diluted	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Common Class A [Member] | As Reported [Member]
Net loss attributed to common stockholders	$ (11,138)	$ (65,025)	$ (46,819)	$ (132,684)
Basic weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Dilutive weighted average common shares outstanding	215,869,537	209,021,924	215,288,148	208,569,794
Loss per share, basic	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Loss per share, diluted	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Common Class A [Member] | Impact of Reverse Stock Split [Member]
Basic weighted average common shares outstanding	(201,478,234)	(195,087,129)	(200,935,605)	(194,665,141)
Dilutive weighted average common shares outstanding	(201,478,234)	(195,087,129)	(200,935,605)	(194,665,141)
Loss per share, basic	$ (0.72)	$ (4.36)	$ (3.04)	$ (8.90)
Loss per share, diluted	$ (0.72)	$ (4.36)	$ (3.04)	$ (8.90)
Common Class A [Member] | Revised [Member]
Net loss attributed to common stockholders	$ (11,138)	$ (65,025)	$ (46,819)	$ (132,684)
Basic weighted average common shares outstanding	14,391,302	13,934,795	14,352,543	13,904,653
Dilutive weighted average common shares outstanding	14,391,302	13,934,795	14,352,543	13,904,653
Loss per share, basic	$ (0.77)	$ (4.67)	$ (3.26)	$ (9.54)
Loss per share, diluted	$ (0.77)	$ (4.67)	$ (3.26)	$ (9.54)
Common Class B [Member]
Net loss attributed to common stockholders	$ (2,866)	$ (17,278)	$ (12,078)	$ (35,332)
Basic weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188
Dilutive weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188
Loss per share, basic	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Loss per share, diluted	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Common Class B [Member] | As Reported [Member]
Net loss attributed to common stockholders	$ (2,866)	$ (17,278)	$ (12,078)	$ (35,332)
Basic weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188
Dilutive weighted average common shares outstanding	55,539,188	55,539,188	55,539,188	55,539,188
Loss per share, basic	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Loss per share, diluted	$ (0.05)	$ (0.31)	$ (0.22)	$ (0.64)
Common Class B [Member] | Impact of Reverse Stock Split [Member]
Basic weighted average common shares outstanding	(51,836,575)	(51,836,575)	(51,836,575)	(51,836,575)
Dilutive weighted average common shares outstanding	(51,836,575)	(51,836,575)	(51,836,575)	(51,836,575)
Loss per share, basic	$ (0.72)	$ (4.36)	$ (3.04)	$ (8.90)
Loss per share, diluted	$ (0.72)	$ (4.36)	$ (3.04)	$ (8.90)
Common Class B [Member] | Revised [Member]
Net loss attributed to common stockholders	$ (2,866)	$ (17,278)	$ (12,078)	$ (35,332)
Basic weighted average common shares outstanding	3,702,613	3,702,613	3,702,613	3,702,613
Dilutive weighted average common shares outstanding	3,702,613	3,702,613	3,702,613	3,702,613
Loss per share, basic	$ (0.77)	$ (4.67)	$ (3.26)	$ (9.54)
Loss per share, diluted	$ (0.77)	$ (4.67)	$ (3.26)	$ (9.54)

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) $ / shares in Units, $ in Thousands				6 Months Ended
	Aug. 04, 2023 USD ($) Employees $ / shares shares	Jul. 21, 2023	Jul. 10, 2023 USD ($) $ / shares	Jun. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares
Subsequent Event [Line Items]
Reverse Stock Split description				On July 6, 2023, the Company’s board of directors approved the Reverse Stock Split at a ratio of (a) one (1) new share of Class A Common Stock for fifteen (15) shares of Class A Common Stock then issued and outstanding; and (b) one (1) new share of Class B Common Stock for fifteen (15) shares of Class B Common Stock then issued and outstanding. The Reverse Stock Split is expected to be consummated on or before October 2, 2023, by the filing of an amendment to the Company’s Second Amended and Restated Certificate of Incorporation.
Cash and cash equivalents				$ 13,384	$ 33,644
Dismissal date of amended complaint		Jul. 21, 2023
Plaintiffs action				The plaintiffs in this action have a period of 21 days to file an amended complaint.
Warrant condition	Certain of those conditions in the Purchase Agreement include, but are not limited to: (i) the daily VWAP (as defined in the Warrants) of the Class A Common Stock on Nasdaq is not less than $1.00, (ii) after giving pro forma effect to the proposed subsequent closings, the Company’s pro forma indebtedness does not exceed certain specified relative percentages of its market capitalization, (iii) the last funding date under the Securities Purchase Agreement was at least 90 days prior to the proposed subsequent closing, (iv) on the subsequent closing date, the Company will have aggregate capacity to generate gross proceeds of at least $20.0 million under an approved at-the-market equity program and/or equity line; and (v) if the Company reports cash and cash equivalents of less than $50.0 million at the end of the calendar quarter immediately preceding the date of such Additional Notes purchase, the Company’s Available Cash (as defined in the Purchase Agreement) on the last calendar day of such quarterly period must be greater than or equal to (x) the sum of the Company’s cash and cash equivalents on the last calendar day of the immediately preceding calendar quarter, less (y) $10.0 million. No offer to sell Additional Notes to the Investor may occur earlier than two trading days following the Company’s public announcement of its earnings for the fiscal year ended December 31, 2023 and no later than August 4, 2024.The Securities Purchase Agreement also provides that for (i) 60 calendar days after August 4, 2023 and (ii) 45 days after each subsequent closing date pursuant to the Securities Purchase Agreement, the Company and its subsidiaries may not, directly or indirectly, register, offer, sell, grant any option or right to purchase, issue or otherwise dispose of, including make any filing to do the same, any equity or equity-linked securities, subject to limited exceptions, including without limitation, sales pursuant to the Sales Agreement.
Common Class A [Member]
Subsequent Event [Line Items]
Common stock, par value | $ / shares				$ 0.0001	$ 0.0001
Common stock, shares issued | shares				216,481,966	216,481,966
Common stock, shares outstanding | shares				213,697,468	213,697,468
Common Class B [Member]
Subsequent Event [Line Items]
Common stock, par value | $ / shares				$ 0.0001	$ 0.0001
Common stock, shares issued | shares				55,539,188	55,539,188
Common stock, shares outstanding | shares				55,539,188	55,539,188
Subsequent Event [Member]
Subsequent Event [Line Items]
Remain available for issuance	$ 20,000		$ 20,000
Adjustment Increase Decrease Cash and CashEquivalents	$ 10,000
Interest rate accrual	15%
Debt instrument accelerated redemption price percentage	115%
Unrestricted and unencumbered cash and cash equivalents	$ 20,000
Restricted cash	8,000
Total purchase price of initial note	12,100
Proceeds from debt net of issuance costs	$ 6,029
Percentage of number of positions eliminated	25%
Restructuring and related cost, Description	The affected employees primarily supported the Company’s launch services, selling, general and administrative and shared services functions and will be paid their base compensation for a period of 60 days consistent with the Company’s normal pay periods.
Number of positions transferred | Employees	50
Number of positions | Employees	70
Subsequent Event [Member] | Minimum [Member]
Subsequent Event [Line Items]
Remain available for issuance	$ 20,000
Subsequent Event [Member] | Senior Notes [Member]
Subsequent Event [Line Items]
Outstanding principal	$ 12,500
Senior note maturity date	Nov. 01, 2024
Annual interest rate	9%
Increase in interest rate in the event of default	15%
Percentage of outstanding principal amount	105%
Unrestricted and unencumbered cash and cash equivalents	$ 15,000
Restricted cash	5,000
Proceeds from debt net of issuance costs	10,800
Unamortized discount	6,500
Debt issuance cost	1,300
Debt issuance cost, fee amount	$ 400
Interest rate, effective percentage	62.45%
Subsequent Event [Member] | Senior Notes [Member] | Warrant [Member]
Subsequent Event [Line Items]
Warrants exercise price per share | $ / shares	$ 0.45
Proceeds from the loan proportionately to the Term Loan and to the Warrants	$ 4,800
Debt issuance cost	4,800
Subsequent Event [Member] | Senior Notes [Member] | Minimum [Member]
Subsequent Event [Line Items]
Outstanding term loan advances	5,000
Subsequent Event [Member] | Senior Notes [Member] | Term Loan [Member]
Subsequent Event [Line Items]
Senior note, net cash proceeds	$ 12,100
Subsequent Event [Member] | Common Class A [Member]
Subsequent Event [Line Items]
Warrants purchased | shares	22,500,000
Subsequent Event [Member] | Common Class A [Member] | Senior Notes [Member] | Minimum [Member] | Warrant [Member]
Subsequent Event [Line Items]
Warrants exercise price per share | $ / shares	$ 1
Subsequent Event [Member] | Common Class A [Member] | Roth Capital Partners LLC [Member]
Subsequent Event [Line Items]
Common stock, par value | $ / shares			$ 0.0001
Offer and sales under agreement			$ 65,000
Subsequent Event [Member] | Common Class B [Member] | Roth Capital Partners LLC [Member]
Subsequent Event [Line Items]
Offer and sales under agreement			$ 50,000
Subsequent Event [Member] | Additional Notes [Member] | Maximum [Member]
Subsequent Event [Line Items]
Cash and cash equivalents	$ 50,000
Subsequent Event [Member] | Additional Notes [Member] | Senior Notes [Member]
Subsequent Event [Line Items]
Outstanding principal	$ 7,500
Subsequent Event [Member] | Additional Notes [Member] | Common Class A [Member]
Subsequent Event [Line Items]
Percentage of aggregate principal amount of the Additional Notes	65%

Subsequent Events - Summary of

Subsequent Events - Summary of Fair Value of Initial Warrants Using Black-Scholes Option Pricing Model (Details) - $ / shares		6 Months Ended
	Aug. 04, 2023	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant-date fair value		$ 0.4
Exercise Price		$ 0.52
Warrant [Member] | Subsequent Event [Member] | Senior Notes [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected terms	5 years
Expected volatility	93.60%
Risk-free interest rate	3.99%
Expected dividend rate	0%
Grant-date fair value	$ 0.40
Exercise Price	$ 0.45

Subsequent Events - Summary o_2

Subsequent Events - Summary of Net Proceeds After Deducting Issuance Costs and Fair Value (Details) - Subsequent Event [Member] $ in Thousands	Aug. 04, 2023 USD ($)
Subsequent Event [Line Items]
Senior Note Principal	$ 12,500
Less: lender original issue discount	375	[1]
Net cash proceeds	12,125
Less: cash expenses for third-party issuance costs	1,285	[1]
Net proceeds after lender fees and third-party issuance costs	10,840
Less: Discount associated with fair value of Warrants	4,811	[1]
Senior Note, net proceeds after lender fees, third-party issuance costs and Warrants	$ 6,029
[1] amounts will be accounted for as debt discount and amortized to interest expense over the term of the loan using the effective interest method.

Subsequent Events - Summary o_3

Subsequent Events - Summary of Carrying Value of Initial Note (Details) - Subsequent Event [Member] $ in Thousands	Aug. 04, 2023 USD ($)
Subsequent Event [Line Items]
Senior Note	$ 12,500
Less: Unamortized debt discount and issuance costs	(6,471)
Carrying value of Senior Note	$ 6,029